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ABSTRACT 
Histone modifying enzymes and chromatin remodeling complexes play an important 
regulatory role in chromatin dynamics that dictate the interaction of regulatory factors 
involved in processes such as DNA replication, recombination, repair and transcription, 
with DNA template. The CHD (Chromodomain Helicase DNA Binding Protein) family of 
proteins is known to be involved in the regulation of gene expression, recombination 
and chromatin remodeling via their chromatin specific interactions and activities. 
Phenotypic analysis of the Chd2 mutant mouse model developed by our laboratory 
indicates that the Chd2 protein plays a critical role in tumor suppression as the 
heterozygous mutant mice develop spontaneous lymphomas. In this study we 
demonstrate that mutation of Chd2 renders cells susceptible to inefficient DNA repair 
and genomic instability. Homozygous and heterozygous Chd2 mutant mouse embryonic 
fibroblast accumulates higher levels of gamma-H2AX after DNA damage. Chd2 mutant 
cells show inefficiency in DNA repair of DNA lesions induced by X-rays and UV 
irradiation as assessed by single cell gel electrophoresis assays. These cells also 
exhibit increased chromosomal aberrations after treatment with low doses of X-ray 
irradiation (2 Gy) and show increased radiosensitivity in a clonogenic survival assay.  At 
the molecular level, endogenous CHD2 protein level is induced after exposure to X-ray 
radiation. In addition, we have also demonstrated in this study that CHD2 is 
phosphorylated after DNA damage and is a potential substrate for phosphoinositide 3-
kinase-related kinases (PIKK) - ATM/ATR. Additionally, mass spectrometric analysis 
showed possible association of CHD2 with the paraspeckle family of proteins known to 
be involved in an array of cellular processes specifically in RNA processing and DNA 
repair. An in vivo splicing assay demonstrated that CHD2 played a role in modulation of 
pre-mRNA splicing event.  Collectively, our findings suggest that CHD2 is a multi-
functional protein working with the paraspeckle protein complex to facilitate both the 
pre-mRNA splicing process and the initial DNA repair process. CHD2 may also be 
involved in the later stages of DNA damage response pathway by influencing p53‟s 
transcriptional activity. 
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Chapter I 
General Introduction 
Structure of Chromatin 
Organization of DNA within the eukaryotic nucleus is a complex process. The 
organization of DNA involves its folding into a highly compact structure called 
chromatin.  The basic structure of chromatin consists of the nucleosome, which contains 
146 base pairs of DNA wrapped around the histone octamer. A histone octamer is 
composed of two molecules each of the histones H2A, H2B, H3 and H4[1]. The 
nucleosomes are arranged in a sequential manner by linker DNA of variable length to 
form a structure known as "beads-on-a-string". This 10 nm "beads-on-a-string" fiber is 
further condensed into a 30 nm diameter helical structure by linker histone H1[2].  The 
highly compact structure of the chromatin blocks access to the naked DNA for various 
nuclear factors involved in cellular processes such as replication, repair, recombination, 
and transcription.  Accessibility to the DNA needs to be positively and negatively 
regulated in order to ensure smooth functioning of the cell. Some factors such as 
histone modifying and chromatin remodeling complexes help to open up the chromatin 
structure thereby allowing accessibility to the DNA template during replication, repair, 
recombination, and transcription. Other factors such as the chromatin assembly factor-I 
(CAF) help to restore the original structure of chromatin once the necessary cellular 
processes are completed [1]. 
 
Histone modifying complexes 
Histones are the basic organizational unit of the chromatin.  Histones play an 
important role in the regulation of gene expression by modifying chromatin structure.  
Each of the core histones (H2A, H2B, H3 and H4) contains a N-terminal tail, which 
protrudes outside the compact chromatin structure and thus is susceptible to a variety of 
covalent post-translational modifications [3].  These covalent modifications act as an 
“epigenetic code” for chromatin remodeling factors or transcription factors to regulate 
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gene expression [4].  The post-translational modifications include phosphorylation, 
acetylation, methylation, ubiquitination, sumoylation, ADP ribosylation, glycosylation, 
biotinylation and carbonylation[2]. Phosphorylation, acetylation and methylation are 
some of the best understood and well-studied post-translational modifications. 
 
Histone acetylation  
Acetylation occurs at specific lysines on the core histones‟ tail which neutralize the 
positive charge of the epsilon amino group of the lysine residues. This modification 
weakens the interaction between the histones and the negatively charged DNA, 
resulting in an open chromatin structure [5-6]. Recent studies suggest histone 
acetylation patterns dictate a variety of downstream processes including transcription, 
DNA repair, and telomere silencing. For example, acetylation of histone H3K56 helps in 
maintaining genome stability. Acetylation of phospho-H2Av by the Drosophila dTip60 
complex facilitates removal of phospho-H2Av after DNA damage repair [7]. Histone 
H4K16 Acetylation is associated with formation of high-order chromatin structure in 
D.melanogaster and histone H4K12 acetylation is associated with the repression of 
transcription in S.cerevisiae and D.melanogaster [5].  Two classes of enzymes are 
involved in the regulation of histone acetylation: histone acetyl-transferases (HATs) and 
histone deacetylases (HDACs). Histone acetyl-transferases (HATs) activity is 
possessed by many transcriptional coactivators such as Gcn5/PCAF, CBP/p300, and 
SRC-1. Acetylation of histones is reversed by histone deacetylases (HDACs), which 
promotes the condensation of the nucleosomal fiber [8]. Transcriptional corepressors 
possessing histone deacetylases such as mSin3a, NCoR/SMRT, and NURD/Mi-2 are 
responsible for restoring the native chromatin structure [5].  A disturbance in the 
balance between the HATs and HDACs activities result in the origin of a variety of 
cancers [6]. 
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Histone methylation and demethylation 
The process of methylation can occur on both lysine and arginine residues. Mono or 
dimethylation occurs on the 17th arginine residue in histone H3 and on the 3rd arginine 
residue in histone H4 [9-10]. Lysine 4, 9, 27, 36 and 79 of histone H3 and lysine 20 of 
histone H4 are mono, di or trimethylated. Histone H3K4 and H3K36 methylation is 
associated with transcription activation while methylation of H3K9, H3K27, H3K79 and 
H4K20 signals for the silencing of transcription [11]. Histone methylation is brought 
about by histone methyltransferases (HMTs). HMTs transfer the methyl group from s-
adenosylmethionine (SAM) to the side-chain nitrogen of lysine or arginine residues [6]. 
There are three classes of HMTs : arginine methyltransferases, SET domain containing 
lysine methyltransferases, and Dot1-like lysine methyltransferases [6].  Histone arginine 
methylation is carried out by the coactivator arginine methyltransferase (CARM1) and 
the protein arginine methyltransferase (PRMT1) [5].  SET domain containing lysine 
methyltransferases methylate specific lysines on histone H3 and H4. Some examples of 
SET domain containing lysine methyltransferases include Ezh2, PR-Set7, Set1, Set2, 
Suv4-20h1, and Suv4-20h2 [6]. Dot1 (disruptor of telomeric silencing-1) -like lysine 
methyltransferases need a nucleosomal substrate and thus cannot methylate free 
histones. An example of Dot1-like lysine methyltransferases is Dot1 which mono, di, or 
trimethylates H3K79. This methylation is required for telomere-associated gene 
silencing [5].  Methylation of histones is counterbalanced by reversing the process 
through histone demethylation. Two classes of enzymes, amine oxidases such as 
LSD1(lysine specific demethylase1) and hydrolases of the JmjC (Jumonji) family have 
recently been found to demethylate a specific lysine on histones [12]. LSD1 is capable 
of demethylating mono- or di- methylated H3K4, thus functioning as a transcriptional 
repressor [6]. JmjC family members can demethylate lysine of H3K4, H3K9, H3K27, 
and H3K36 [5].  Arginine methylation is reversed by arginine deiminase, PADI4/PAD4 
(peptidyl arginine deiminase 4), which converts the methyl-arginine residue into 
citrulline. This deimination process is associated with silencing of the oestrogen-
controlled gene, pS2 [12].  
  
4 
 
Histone phosphorylation 
Phosphorylation of histones occurs at specific sites on serine and threonine and it is 
associated with different processes such as transcriptional activation and chromosome 
condensation during meiosis and mitosis [4]. The onset of metaphase in mitosis marks 
the phosphorylation of histone H3S10 by aurora kinase B which abolishes methylation 
of histone H3K9 and removes HP1(heterochromatin protein 1) from chromosomes [13].  
By contrast, during prophase aurora kinase B comes back to phosphorylate histone 
H3S28 causing chromosome condensation. Similarly, phosphorylation of H2B at serine 
14 by Mst1 (mammalian sterile twenty) kinase is correlated with chromosome 
condensation during meiosis.  Phosphorylation of histone H3S10 by MSK1/2(mitogen 
and stress-activated protein kinase 1 and 2) initiates transcription of mitogen-stimulated 
immediate-early response genes [4-5].  Another well studied phosphorylated histone is 
histone H2AX which can be mediated by any of the following: phosphatidylinositol-3-OH 
kinase-related kinase (PIKK) family- ataxiatelangiectasia mutated (ATM), ataxia 
telangiectasia related (ATR) or DNA-dependent protein kinase (DNA-PK). Histone 
H2AX phosphorylation occurs on serine 139 and is triggered by the formation of DNA 
double-strand breaks (DSBs) after DNA damage [14]. H2AX phosphorylation (γ-H2AX) 
acts as an initial signal for the recruitment of DNA damage checkpoint and repair 
proteins to the damaged regions [14]. γ-H2AX also helps in recruiting cohesins to the 
damaged regions. Cohesins keep the sister chromatids together, thus helping in 
homologous recombination to repair the damaged DNA strand with the undamaged 
DNA strand serving as the template. After completion of the repair process, protein 
phosphatase 2A (PP2A) dephosphorylates chromatin-associated γ-H2AX and removes 
it. The mechanism by which PP2A removes the dephosphorylated γ-H2AX is not 
known. The removal of γ-H2AX facilitates segregation of sister chromatids [15].  
 
Chromatin remodeling complexes 
The proteins present in this group are also known as ATP-dependent chromatin 
remodeling factors. These proteins, as the name suggests, utilize the energy derived 
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from ATP hydrolysis to modulate chromatin fluidity [16-17].  All ATP-dependent 
chromatin remodeling factors contain a highly conserved ATPase subunit belonging to 
the Swi2/Snf2 ATPase superfamily. There are four classes of the ATPase subunit- SWI 
(switching)/ SNF (sucrose non-fermenting), ISWI (imitation switch), CHD 
(Chromodomain helicase DNA binding), and INO80. All of the ATP-dependent 
chromatin remodeling factors are classified under the aforementioned classes, 
depending upon which type of ATPase subunit they possess [17].  
 
The class of SWI/SNF 
This class of ATP-dependent chromatin remodeling factors includes the yeast SWI 
(switching)/ SNF (sucrose non-fermenting) complex, the yeast RSC (remodels the 
structure of chromatin) complex, Drosophila melanogaster brahma complex, and the 
mammalian BRG1 and BRM complex. The Swi2/Snf2-like ATPase subunits present in 
these complexes exhibit DNA-dependent ATPase activity. Other conserved motifs 
between these proteins include the presence of a C-terminal bromodomain and two 
other conserved regions (domains I and II) of unknown function [16].  The yeast SWI 
(switching)/ SNF (sucrose non-fermenting) complex was the first ATP-dependent 
chromatin remodeling factor to be discovered [18-19]. The genes were named SWI / 
SNF, as they were discovered during a genetic screen for factors needed for mating-
type switching and use of sucrose as a carbon source [20]. The SWI/SNF complex is 
required for inducing transcription of both the homothallic switching (HO) endonuclease 
and the sucrose hydrolyzing enzyme (SUC2) genes [17].  Studies elucidating the 
functions of SWI/SNF complex show that this complex can bind to both DNA and 
nucleosomes. The complex alters the position/structure of nucleosomes on arrays 
increasing the access to DNA for transcriptional activators or repressors [21]. The yeast 
RSC (remodels structure of chromatin) complex contains 15 ATPase subunits. Four out 
of the fifteen [Sth1 (for Snf2 homolog), Rsc8/Swh3 and Rsc6] are homologous to 
SWI/SNF subunits [16]. Unlike the SWI/SNF subunits, the four homologous subunits of 
RSC complex are essential for mitotic growth and necessary for cell viability [22]. 
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Localization of the RSC complex to Pol III and Pol II promoters shows its involvement in 
the regulation of transcription [23]. Its involvement in chromatin remodeling includes the 
transferring of histone octamers from one DNA to another [16, 22].  Unlike the yeast 
system, Drosophila melanogaster contains only one Swi2/Snf2- like ATPase, the 
brahma (BRM) protein. D.brahma is an activator of homeotic genes and is required for 
cell viability. BRM has been shown to associate with RNA polymerase II and 
hyperacetylated chromatin, suggesting a functional role of BRM in gene activation [24].  
Human/mammalian cells have two SWI2/SNF2 homologs, BRG1 and human BRM. 
Both of these proteins form separate complexes and in vitro studies show that both are 
involved in alteration of nucleosome structures [22].  BRG1 has been shown to 
associate with tumor-suppressor proteins retinoblastoma (pRB) and BRCA1. Both 
BRG1 and BRM demonstrate a role in the tissue differentiation process [17].  A BRG1- 
containing coactivator complex, E-RC1 (EKLF coactivator-remodeling complex 1) 
creates an open chromatin structure to facilitate EKLF-dependent transcription of the  
human β-globin gene [16]. 
 
The class of ISWI 
Drosophilia ISWI (imitation switch) complexes are the founding members of this 
class. The members of the ISWI class posses the SLIDE domain, and the HAND-SANT 
domain in addition to the ATPase domain.  The SLIDE domain which resembles a myb-
like DNA binding domain is known to play an important role in nucleosome recognition 
and the HAND-SANT domain is known to interact with histone tails [25]. ISWI is the only 
member of this class in Drosophilia and is part of three chromatin remodeling 
complexes: NURF (nucleosome remodeling factor), ACF (ATP-utilizing chromatin 
assembly and remodeling factor), and CHRAC (chromatin accessibility complex).  
These complexes use ATP hydrolysis to alter chromatin by creating regularly spaced 
nucleosomal arrays [24].  Drosophilia ISWI is the involved in maintenance of the male X 
chromosome structure and is also found to be essential for cell viability[16].  Co-
localization studies of ISWI with RNA polymerase II show no interaction, speculating a 
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negative role of ISWI in transcription regulation [26].  Isw1 and Isw2 are two members of 
yeast ISWI which, along with other proteins form two distinct complexes involved in 
ATP-dependent nucleosome disruption. Isw2 complex and Isw1/Ioc3 complex are 
known to be involved in displacement of the basal transcription machinery to silence 
gene expression, whereas Isw1/Ioc4/Ioc2 complex regulates transcription elongation 
and termination [27].  Isw2 complex is also involved in formation of a „nuclease-
inaccessible chromatin structure in vivo‟[17]. The mammalian system contains two ISWI 
proteins; SNF2H and SNF2L. The SNF2H forms a part of the RSF (remodeling and 
spacing factor) along with p325 in humans, which is involved in nucleosomal spacing 
and transcription initiation. SNF2H is also found as a subunit in WICH complex (WSTF 
[Williams‟s syndrome transcription factor] −ISWI chromatin remodeling complex) which 
is required for DNA replication. SNF2H has also been purified as a subunit from human 
CHRAC complex and SNF2L from human NURF complex[25].  
 
The class of INO80 
The INO80 complex was first isolated in a genetic screen for yeast mutants defective 
in transcriptional activation in response to inositol depletion [28] . This class possesses 
a unique ATPase called Ino80p/Swr1 ATPase, which splits into two because of the 
presence of a spacer between the domains [29].  The INO80 class consists of two 
complexes: INO80 remodeling complex (INO80.com) and SWR1 remodeling complex 
(SWR1.com). The INO80 complex consists of Ino80, Rvb1, Rvb2, Arp4 (actin-related 
protein 4), Arp5, Arp8, actin, Nhp10 (nonhistone protein 10), Anc1/Taf14, Ies1 (ino 
eighty subunit 1), Ies2, Ies3, Ies4, Ies5 and Ies6. The human INO80.com consists of the 
Gli-Kruppel zinc finger transcription factor Yin Yang 1 (YY1), the deubiquitylating 
enzyme Uch37 and nuclear factor related to kB (NFRKB) as its subunits. Drosophila 
INO80 complex has subunits similar to the human INO80 complex [28].  INO80 complex 
is involved in positive and negative regulation of transcription through its ATP-
dependent chromatin remodeling activity [28].  Studies have also demonstrated INO80‟s 
important role in DNA repair. INO80.com is recruited to DNA double strand break (DSB) 
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sites via its interaction with γ-H2AX and helps in recruiting  DNA repair proteins through 
its chromatin remodeling activities [30].  INO80.com along with another chromatin 
remodeler, Iswip helps in fork movement during DNA replication through remodeling of 
nucleosomes[28]. The SWR1 remodeling complex is composed of the subunits: Swr1, 
Swc2/Vp372, Swc3, Swc4/Eaf2/God1, Swc5/Aor1, Swc6/Vps71, Swc7, Yaf9, Bdf1, 
Act1/actin, Arp4, Arp6, Rvb1 and Rvb2. SWR1.com functions as a replacement 
apparatus by replacing the H2A–H2B dimer in the nucleosome with H2AZ–H2B. Other 
functional studies on SWR1.com demonstrate a similar role as INO80.com in DNA 
repair process [29]. 
 
The class of CHD proteins 
The Chromodomain helicase DNA binding proteins(CHD) are a group of highly 
conserved proteins sharing sequence motifs and functional domains such as chromo 
(chromatin organization modifier) domains, SNF2-related helicase/ATPase domains, 
specific DNA binding domains, and the C-terminal helicase domains associated with 
regulation of chromatin structure and gene transcription [31]. CHD proteins regulate 
ATP-dependent nucleosome assembly via their chromodomains and SNF2-related 
helicase/ATPase domains [32-33]. The CHD family of proteins is present in eukaryotic 
organisms like Caenorhabditis elegans, yeast, Drosophila, mice, and humans [34]. 
According to The Human Genome Organization, the mammalian CHD family contains 
nine members. The family can be further subdivided into three subfamilies according to 
the presence of additional functional domains and the type of chromodomains (CDs) 
present (http://www.gene.ucl.ac.uk/nomenclature/) (Fig.1).  CHD1 and CHD2 belong to 
subfamily I. CHD3 and CHD4 belong to the second subfamily. The third subfamily is 
comprised of the CHD proteins five through nine. The CHD1 and CHD2 subfamilies 
both contain chromodomains of subclasses 0 and H. These two proteins share CDs and 
Myb DNA binding domains, which are identical to each other. The CHD3 and 4 
subfamilies contain CDs of subclasses P and J and also contain a pair of N-terminal 
PHD Zn-fingers that are not present in other CHD sub-families. The CHD-6 subfamily 
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contains CD subclasses Q and I with BRK and/or SANT DNA binding domains in the C-
terminal region [35].  
 
The shared domains of CHD family: 
The chromodomain: The chromodomain (chromatin organization modifier) is a 
domain of 40-50 amino acids present in proteins involved in chromatin remodeling and 
regulation of gene expression in eukaryotes during development. The best studied 
examples of such proteins are found in Drosophila melanogaster. This includes 
Heterochromatin Protein 1(HP1), the histone acetyltransferase MOF, Polycomb, and 
Suppressor of variegation and their homologues in other organisms [35].  The 
chromodomain binds to methylated histones and has been found to act as recognition 
motifs for methylated lysine-9 of histone H3. Chromodomains are shown to interact with 
RNA and also self-associate with one another[16].  
The SNF2-related helicase/ATPase domain:  This domain is  ~400 amino acids long 
and consists of two subdomains: “a conserved N-terminal subdomain I required for ATP 
binding and hydrolysis and a C-terminal subdomain involved in energy transduction” 
[34]. The SNF2 related ATP dependent helicase domain functions to processively move 
along DNA templates and destabilize protein-DNA interactions[31]. SNF2/SWI2 is the 
ATPase of the S.cerevisiae SWI/SNF complex. The SWI/SNF complex is also known to 
remodel chromatin structure to facilitate binding of gene specific transcription factors. 
SNF2 also participates in a number of DNA related processes including DNA repair, 
chromatin remodeling, recombination and transcription [16, 36-37]. 
 
Chromodomain helicase DNA binding protein 1 (CHD1) 
Mouse Chd1 was the first chromdomain helicase DNA binding protein to be 
characterized by Delmas et al. in 1993 [36]. Subsequently, Woodage et al. mapped the 
human CHD1 gene to 5q15-q21 by PCR screening of the CEPH YAC library [31]. 
Human CHD1 encodes a 1,709-amino acid protein and shares a 95% homology to the 
mouse Chd1 [31]. CHD1 protein has two chromodomains near the N-terminus, a  
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Schematic representation of the structural domains present in CHD subfamilies 
(adapted from Hall and George, 2007)     
 
 
 
 
 
Figure 1.Structural domains of CHD proteins 
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centrally located Snf2-related helicase/ATPase domain and a Myb-related DNA binding 
domain at the C-terminus [36]. A search for proteins that bind a DNA promoter elements 
led to the identification of murine Chd1 , which was found to bind to immunoglobulin 
promoter sequences [36]. Following the above findings, Stokes and Perry showed that 
Chd1 binds to (A+T)-rich DNA via minor-groove interactions [38]. It was demonstrated 
that Chd1 has a “cell cycle –related localization pattern” as it localized to the cytoplasm 
at the beginning of mitosis and then became part of the chromatin during telophase-
cytokinesis.  Chd1 was designated as “constituent of bulk chromatin” and had to be 
treated with salt and micrococcal nuclease to purify from the nucleus [38]. 
Characterization of the Drosophila melanogaster Chd1 homologue was also reported in 
1996 [39]. The expression of the protein was localized to interbands on polytene 
chromosomes and a functional role for Chd1 in chromatin remodeling was speculated 
[39]. In vivo chromatin assembly studies in Drosophila provide evidence that Chd1 is a 
factor involved in assembly of histone variant H3.3 containing nucleosomes and it 
interacts with Drosophila histone chaperone HIRA [40].  Drosophila Chd1 co-localizes 
with elongating RNA polymerase II, but is not required for RNA polymerase II‟s 
association with chromatin[41]. Drosophila Chd1 is an important factor for female and 
male fertility [41]. The orthologos of CHD1 and the nuclear protein structure-specific 
recognition protein 1(SSRP1) were found to interact and the two proteins were shown to 
co-localize in Drosophila polytene chromosomes [42].  SSRP1 is part of the FACT 
(facilitates chromatin transcription) complex in mammals. SSRP1 interacts with Rad54 
and plays an important role in the HR-mediated DNA damage response [43]. 
Saccharomyces cerevisiae Chd1 was shown to interact with Rtf1, a component of the 
Paf1 complex The Paf1 complex associates with RNA polymerase II and regulates 
transcription elongation. Chd1 also interacts with components of two elongation factors 
Spt4-Spt5 and Spt16-Pob3 [44].  Other functional studies of CHD1 suggest a role for 
the protein in active chromatin assembly and as a component of yeast SAGA (Spt-Ada-
Gcn5 acetyltransferase) and SLIK (SAGA-like) histone acetyltransferase complex [45-
46].  
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Saccharomyces cerevisiae Chd1 has been found to have a role in the regulation of 
the ADH2 (alcohol dehydrogenase 2) gene and is required for ADH2 promoter 
nucleosome organization [47].  Yeast Chd1 plays an antagonistic role to yFACT (yeast 
facilitates chromatin transcription) complex in regulation of TBP (TATA binding protein) 
binding at promoters in yeast [48]. Set2(a histone methyltransferase that methylates 
K36 of histone H3) and Chd1 negatively regulate DNA replication possibly through 
negative regulation of DNA replication factors recruited by yFACT  to stabilize the 
replication fork [49]. Comparative analysis of yeast and human CHD1 showed that only 
the chromodomains of human CHD1 interacts with methylated lysine 4 on histone H3 
[33, 50]. Mouse Chd1 has been suggested to have a functional role in the repression of 
gene expression by virtue of its interaction with NCoR, a co-repressor of nuclear 
hormone receptor transcription factor [51]. CHD1 is also associated with histone 
deacetylase activity and has a role in pre-mRNA splicing [51]. CHD1 has been 
proposed to function as a recruiter of U2 snRNP and FACT/PAF to the first nucleosome. 
This recruitment has been shown to boost the efficiency of pre-mRNA splicing and 
transcript elongation [52]. Recent studies on Bombyx mori follicle development, led to 
the identification of the silkmoth chromo-helicase/ATPase-DNA binding protein 1 (Chd1) 
ortholog [53].  The silkmoth ortholog of Chd1 binds to the chorion gene promoter 
element and repositions the nucleosomes. This repositioning allows accesses to C/EBP 
and TFIID to the promoter elements which initiate transcription [53]. More recently, 
Chd1 has been reported as an essential gene for maintaining both pluripotency and an 
open chromatin structure in the embryonic stem cells [54]. 
The focus of this thesis is Chromodomain helicase DNA binding protein 2(CHD2), 
which will be discussed in chapter II of the thesis. 
 
Chromodomain helicase DNA binding proteins 3 and 4 (CHD3 and CHD4) 
CHD3 and CHD4 belong to the second subfamily. These proteins are also called Mi-
2α and Mi-2β. Mi-2 proteins were first identified as autoantigens in the connective tissue 
disease dermatomyositis [55-56]. The domain unique to this subfamily is a PHD (plant 
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homeo domain) Zn-finger-like domain also known as LAP [57]. The PHD or leukemia 
associated protein (LAP) domain is a ~60 amino acid domain found in proteins mainly 
involved in transcriptional regulation. Mutations in the PHD domain of genes such as 
recombination activating gene 2 (RAG2), Inhibitor of Growth (ING), nuclear receptor-
binding SET domain-containing 1 (NSD1) and Alpha Thalassaemia and Mental 
Retardation Syndrome, X-linked (ATRX) have been connected to diseases such as α-
thalassemia, head and neck squamous cell carcinoma, Williams‟s syndrome and 
myeloid leukemias [58-59].  Mi-2α and Mi-2β form a “multi-subunit protein complex 
containing both histone deacetylase and nucleosome-dependent ATPase subunits”, 
known as the NuRD(nucleosome remodeling deacetylase) complex [57].  The NuRD 
complex consists of seven polypeptides including histone deacetylases 1 (HDAC1) and 
HDAC2, H4 interacting proteins-retinoblastinoma-associated proteins 46 and 48 
(RbAp46/48), methyl-CpG-binding domain-containing protein 3 (MBD3), metastasis-
associated protein family members (MTA1 to MTA3), and CHD3/4 [60]. The NuRD 
complex has been recognized in mammals and Xenopus, and homologs of NuRD 
subunits have been identified in Drosophila, Caenorhabditis elegans, and Arabidopsis 
[61].  CHD3/4 in the NuRD complex utilizes ATP to remodel nucleosomes, giving 
access to HDAC1 and HDAC2 to deacetylate the histone tails. The deacetylated 
histones form a compacted nucleosomal structure, thus negatively regulating 
transcription [62]. An example of this type of negative regulation is the MTA3-containing 
NuRD complex. This complex acts as a corepressor for BCL-6 to regulate expression of 
MHC class II through repression of Blimp-1in B lymphocyte [63]. In addition, CHD3 and 
CHD4 interact with pericentrin, which is an integral centrosomal component.  The 
interaction recruits pericentrin to the centrosome, affecting microtubule and spindle 
function. Pericentrin levels increase during mitosis and fall upon entry into the G1 
phase. The pericentrin levels are positively regulated by CHD3, which remains 
associated with pericentrin throughout mitosis. Pericentrin levels are negatively 
regulated by CHD4, which dissociates from the centrosome during mitosis. The 
mechanism as to how CHD3/CHD4 controls the levels of pericentrin is not known. But it 
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is speculated that CHD3 “acts as a structural anchor for pericentrin” and CHD4 is 
“responsible for regulating the removal of pericentrin from the centrosome” [64]. The two 
homologs of Mi-2 in Caenorhabditis elegans, Let-418 and Chd3, play an important role 
in vulval cell fate determination through regulation of the Ras signaling pathway and 
Notch signaling [65].  The Chd3 homolog, PICKLE (Pkl), in Arabidopsis is involved in 
repression of seed-associated genes through facilitating trimethylation of histone H3 
lysine 27 [66].  Drosophila Chd4/dMi-2 and dChd3 are involved in ATP-dependent 
remodeling of nucleosomes and colocalize with RNA polymerase II on the 
transcriptionally active region of polytene chromosomes [67]. 
 
Chromodomain helicase DNA binding protein 5 (CHD5) 
CHD5 was identified during the course of mapping genes deleted in 1q36.3 region in 
human neuroblatomas by Thompson et al. [68]. CHD5 contains two PHD zinc-finger 
domains and a DEAH-box-type helicases domain in addition to the common structural 
domains found in the CHD family [68].  DEAH-box-type helicases are RNA-dependent 
ATPases shown to unwind RNA duplexes [69].  CHD5 was shown to be highly 
expressed in fetal brain and cerebellum while negligible expression was seen in a panel 
of neuroblastoma cell lines [68].  Chromosome engineering was used to identify the 
mouse chromosomal region D4Mit190-51 as the region involved in the regulation of 
proliferation, senescence, and apoptosis. The region was also shown to regulate p53 
activity via p19Arf.  Chd5 was identified as the gene in the D4Mit190-51 region 
accountable for the aforementioned tumor-suppressive functions. Mouse D4Mit190-51  
maps to human chromosome 1p36  [70]. CpG island hypermethylation was observed in 
the CHD5 promoter in human cancer cell lines. The hypermethylation was seen to be 
associated with the loss of CHD5 expression and CHD5 expression was restored upon 
treatment with demethylating agents in these cancer cell lines [71]. Somatic 
heterozygous missense CHD5 mutations and promoter methylation of CHD5 were 
identified in some of the ovarian cancer. These observations lead to the speculation that 
biallelic inactivation of CHD5 would lead to ovarian cancers [72].  
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Chromodomain helicase DNA binding protein 6 (CHD6) 
CHD6 contains the additional structural domains SANT (for 'switching-defective 
protein 3 (Swi3), adaptor 2 (Ada2), nuclear receptor co-repressor (N-CoR), transcription 
factor (TF)IIIB')) and TCH/BRK (Breast tumor kinase) domains [73].  The SANT domain 
is a 50 amino acid motif found in many chromatin-remodeling complexes. SANT 
domains are very similar in sequence to DNA-binding domains (DBD) of Myb-related 
proteins [Myb DBDs]. SANT domains are thought to function as “histone-binding 
modules” [74]. CHD6 was found to interact with Nrf2, a transcription factor needed for 
cellular redox homeostasis by a yeast two-hybrid screen [75].  Recently CHD6 has been 
shown to exhibit DNA-dependent ATPase activity, co-localize with phorsphorylated 
forms of RNA polymerase II, and is present in loci of mRNA synthesis [76]. CHD6 is part 
of the PRIC (PPARα-interacting cofactor)-complex and associates with the transcription 
factor Nrf2, implicating a role of CHD6 in gene activation [75, 77]. 
 
Chromodomain helicase DNA binding protein 7 (CHD7) 
CHD7 has been identified as the gene mutated in a congenital syndrome called 
CHARGE syndrome.  The congenital anomalies of the syndrome include choanal 
atresia and malformations of the heart, inner ear, and retina. Seven stopcodon 
mutations, two missense mutations and one mutation at an intron-exon boundary in the 
CHD7 have been identified in 17 patients with CHARGE syndrome [78].  Seven 
heterozygous mutations, two splice and five missense CHD7 mutations, were observed 
in another developmental disorder called Kallmann syndrome (KS). Kallmann syndrome 
is characterized by impaired olfaction and hypogonadism [79]. CHD7 belongs to the 
third subfamily of the CHD proteins and contains two chromodomains, two helicase 
domains, a SANT domain, and two BRK domains [80].  The BRK or the TCH domain is 
a 50 amino acid stretch of unknown function that is also found in the brahma/BRG1 
family of chromatin remodeling enzymes. The presence of BRK domains in chromatin 
remodeling proteins in higher eukaryotes suggest that they play a role in regulation of 
chromatin structure specific to higher eukaryotes [81].  Mouse models with mutations in 
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the Chd7 gene show phenotypes similar to CHARGE syndrome such as cleft palate, 
choanal atresia, septal defects of the heart, haemorrhages, prenatal death, vulva and 
clitoral defects, and keratoconjunctivitis sicca [82].  More recently, homozygous mice 
generated from a mouse model carrying Chd7 deficient gene trapped lacZ reporter 
alleles exhibited prenatal lethality, indicating an important role of CHD7 in mammalian 
development [83].  Recently, chromatin immunoprecipitation on tiled microarrays (ChIP-
chip) studies showed localization of CHD7 to discrete locations along chromatin that 
were specific to each cell type used in the study.  The study also shows that CHD7 
binding correlates with the location of methylated lysine4 of histone H3, speculating a 
role of CHD7 in enhancer mediated transcription [80]. 
 
Chromodomain helicase DNA binding protein 8 (CHD8) 
The DNA-binding transcription factor CTCF (CCCTC binding factor) mediates 
enhancer blocking insulation at sites throughout the genome. CTCF is involved in gene 
regulation, specifically at the chicken b-globin locus and the imprinted IGF2/H19 locus in 
mice and humans [84].  Yeast two-hybrid screens performed to identify proteins 
interacting with CTCF to elucidate essential mechanisms of CTCF insulator in 
chromatin, revealed interaction of CTCF with CHD8 [85]. CHD8 like its other members 
of CHD subfamily III contains a SANT domain and two BRK domains in addition to the 
structural domains common to the CHD family. CHD8 was found at the known CTCF 
target sites, “such as the differentially methylated region (DMR) of H19, the locus 
control region of b-globin, and the promoter region of BRCA1 and c-myc genes”[85].  
Knockdowns of CHD8 highlight its important role in CTCF-dependent insulator function 
and in epigenetic modifications at CTCF binding sites adjacent to heterochromatin. Loss 
of CHD8 resulted in CpG hypermethylation and histone hypoacetylation at CTCF 
binding sites  [85]. A transcription factor called selenocysteine tRNA-activating factor 
(Staf) activates transcription of the human U6 small nuclear RNA from a preassembled 
chromatin. Studies have identified CHD8 as the chromatin remodeling protein needed 
for the efficient Staf mediated transcription of U6[86].  CHD8 is also required for 
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transcription of a Pol II-transcribed gene-IRF3. The study also demonstrated the ability 
of CHD8 to bind to di and trimethylated histone H3lysine 4 [86]. Another CHD8 
interaction study demonstrates interaction of this chromatin remodeling protein with β-
catenin, an essential component of the “canonical” Wnt signaling pathway. The results 
of the study show that CHD8 is recruited to the promoter regions of several β-catenin-
responsive genes and negatively regulates the expression of these genes. Similar 
results were seen with kismet, the Drosophila melanogaster ortholog of Chd8 [87]. 
Duplin (axis duplication inhibitor) a shorter form of CHD8 expressing 749 amino acids of 
the protein was disrupted in mice by homologous recombination. Duplin–/– embryos 
exhibited growth retardation followed by massive apoptosis at E7.5. This mouse model 
highlights the indispensible role of CHD8 in mammalian development [88]. Follow up 
studies to determine the molecular basis for the apoptosis in Chd8-/- embryos led to the 
unearthing of CHD8 interaction with the tumor suppressor protein p53 [89].  CHD8 was 
found to bind to both p53 and histone H1. The formation of this trimeric complex 
resulted in recruitment of histone H1 to the promoter of p53 target genes, thus 
suppressing their expression. These observations suggested that CHD8 expression 
regulates p53-mediated apoptosis [89]. A recent transcriptomic analysis of CHD8-
depleted cells showed that CHD8 “controls the expression of cyclin E2 (CCNE2) and 
thymidylate synthetase (TYMS), two genes expressed in the G1/S transition of the cell 
cycle” [90]. The results of the study show that CHD8 binds to the 5' region of both 
CCNE2 and TYMS genes and also with the elongating form of RNAPII, thus speculating 
CHD8‟s involvement in transcription elongation [90]. 
 
Chromodomain helicase DNA binding protein 9 (CHD9) 
The last member of the subfamily III, CHD9, is also known as CReMM (chromatin-
related mesenchymal modulator). It is found to be expressed in mesenchymal 
progenitors and binds to skeletal tissue-specific promoters CBFA1, biglycan, 
osteocalcin (OC), collagen-II, and myosin in a differential manner. It was also found to 
bind to A/T-rich DNA [91-92].  CReMM is highly expressed in osteoprogenitors and co-
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localizes with GR (glucocorticoid receptor) in osteoblastic cells [93], suggesting its role 
in osteogenic cell differentiation [94]. 
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Chapter-II 
Characterization of Chromodomain Helicase DNA Binding Protein 2 
(Chd2) in mice 
Introduction 
CHD2 is a poorly characterized CHD protein. The human CHD2 gene has been 
mapped to chromosome15q26 [31].  This region is associated with rare genetic 
disorders that lead to growth retardation, cardiac defects, and early post natal lethality 
[95-96].  The human CHD2 is predicted to be an 1828-amino acid polypeptide. It shares 
a 58.6% identity and a 69.5% similarity overall with mouse Chd1. The human CHD2 
shares 95.9% identity with mouse Chd2. The mouse chromodomain helicase DNA 
binding protein 2 is mapped to chromosome 7 D1 and the protein is predicated to 
contain 1827 -amino acids (NCBI Accession:   XP_145698). Chromodomain helicase 
DNA binding protein 2 has the same domain organization as CHD1. CHD2 has two 
chromodomains at the N-terminus, a centrally located Snf2-related helicase/ATPase 
domain, a DEAD-like helicase domain within the Snf2-related helicase domain, a 
helicase domain at the C terminus and a HMG-I domain (A+T hook) at the C terminus 
(Fig.2). However, it has four putative bipartite nuclear localization signals (one at the N-
terminus and three at the C-terminus). This is unlike CHD1 which has one nuclear 
localization signal. The DEAD-like helicase belongs to the DEAD box family of 
helicases. DEAD box proteins are found in all eukaryotes and most prokaryotes [97]. 
The DEAD box proteins have RNA-dependent ATPase and ATP-dependent RNA 
helicase activities and are involved in various aspects of RNA metabolism [97-98]. The 
HGM-I domain (A+T hook), which are also present in the high mobility group (HMG) 
proteins are known to facilitate various DNA related activities such as transcription, 
replication, recombination, and repair. They bind to AT rich regions of DNA and 
chromatin, and induce short and long range changes in structure of their binding sites 
[99]. 
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The structural domains of the Chd2 protein are shown. The domains are represented by 
different shapes and colors according to the key at the bottom of the figure. The length 
of each domain is also shown in the key. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.Schematic representation of mouse Chd2 protein. 
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There are only a few reports in the literature describing possible functions of CHD2.  
A micro-array study attempting to map chromosomal aberrations for congenital 
diaphragmatic hernia (CDH) identified CHD2 as of one of the three genes with a 
missense mutation in samples obtained from patients with CDH [100].  A cDNA 
microarray gene profile of blood cells from urinary bladder cancer patients showed 
downregulation of CHD2 when compared to healthy controls [101]. Gene expression 
data showed a 1.7 fold decrease in Chd2 gene expression in C57BL/6J p53+/- mammary 
glands when compared to BALB/c p53+/- mammary glands  [102]. A homozygous 
deletion at 15q26.2 was found in a Hodgkin‟s lymphoma cell line – HDLM2 by array 
comparative genomic hybridization (aCGH). This region contains only two known 
genes, RGMA and CHD2 [103]. A transcriptional profile study of fibroblasts grown in 
relaxed collagen lattices showed a 3.6 fold inductions in CHD2 expression in relaxed 
fibroblast compared with mechanically stressed fibroblasts [104]. Recently Marfella et al 
showed that Chd2 is important for mouse development and survival. The phenotypic 
analysis of Chd2-mutant mice showed impaired kidney function [105-106]. 
Fluorescence anisotropy binding assays with methylated histone peptide (H3K4me3) 
show that the human CHD2 chromodomain has a 30-fold weaker interaction compared 
to that of the human CHD1 chromodomain [107]. Our observations with the Chd2 
mutant mice show that the haploinsufficiency of Chd2 causes scoliosis [108] and the 
Chd2 protein appears to play a critical role in the development, hematopoiesis and 
tumor suppression [109].  
 
Materials and Methods 
 
cDNA synthesis and reverse transcriptase (RT)- polymerase chain reaction (PCR) 
Total RNA was isolated from different mouse tissues using TRIzol reagent 
(Invitrogen) according to the manufacturer's protocol. Genomic DNA was removed by 
incubating RNA samples with 2U of RNase-free deoxyribonuclease I (Promega) per 3µg 
of RNA for 30 minutes at 370C. First strand cDNA synthesis was performed with 3µg of 
  
22 
 
total RNA using random hexamers and M-MLV reverse transcriptase (Promega).  As a 
negative control, samples containing RNA but no reverse transcriptase were also 
included.  2µl of cDNA was used for PCR. The primer sequences for Chd2 are: 
GGTGGTGATGGCAAGTCTTCAAGT (exon 33); AGGCAAATGAGGCTTCTGAGGATG 
(exon 36). The primer sequences for housekeeping gene L38 (ribosomal protein L38) 
are: TTCGGTTCTCATCGCTGTGAGTGT (forward); 
TCTTGACAGACTTGGCATCCTTCC (reverse). The PCR conditions for Chd2 exons 33-
36 were initial denaturation at 940C for 2 min, followed by 30 cycles at:  940C for 30 sec, 
580C for 30 sec, 720C for 40 sec with a final extension at 720C for 5 mins. The 
conditions for the house keeping gene, ribosomal protein L38 were 940C for 2 min, 
followed by 30 cycles at: 940C for 30 sec, 580C for 30 sec, and 720C for 10 sec. PCR 
products were resolved by agarose gel electrophoresis and stained with ethidium 
bromide. 
 
cDNA synthesis and Real time RT-PCR 
Total RNA was extracted using Trizol according to the manufacturer‟s instructions 
(Invitrogen) from wild type MEFs and mutant MEFs (E14.5). First strand cDNA 
synthesis was performed as mentioned before. Real time PCR was performed using 1μl 
of the 1:10 diluted cDNA using the ABI PRISM 7300 instrument (Applied Biosystems). 
Real time RT-PCR was done in a final volume of 25 μl comprising 1× Master Mix of 
Absolute SYBR Green (Thermo Scientific) and 0.1nM of forward and reverse primers for 
Chd2 (Fwd: GGTGGTGATGGCAAGTCTTCAAGT; Rev: 
AGGCAAATGAGGCTTCTGAGGATG), housekeeping gene ribosomal protein L38 
(Rpl38) (Fwd: TTCGGTTCTCATCGCTGTGAGTGT; Rev: 
TCTTGACAGACTTGGCATCCTTCC). Data were analyzed by averaging triplicates Ct 
(cycle threshold). Levels of Chd2 RNA expression was determined according to the 
 2-ΔΔct method by normalizing to the internal control Rpl38.  
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Generation of polyclonal Chd2 antibodies 
Commercially available cDNA clones that contain various segments of Chd2 were 
used to generate an N-terminal portion of CHD2. cDNA fragment encoding the first 313 
amino acids of Chd2 were generated by restriction enzymes or PCR and then inserted 
into the Pet30A bacterial expression vector, which contains a histidine tag at the N-
terminus. Synthesis of fusion protein was induced for 24 hrs at 200C with 1mM 
isopropyl-β-D-thiogalatoside. His-Chd2 fusion protein was isolated by affinity 
chromatography on a nickel column. A single rabbit was immunized with a His-Chd2 
fusion protein encoding the first 183 amino acids of Chd2. The serum obtained from the 
rabbit was tested for its specificity against recombinant Chd2 peptides.  
 
Immunofluorescence microscopy 
U2OS cells were cultured in Lab-Tek chamber slides (Nunc, Thermo Fisher 
Scientific) and then fixed for 15 min at room temperature in 3.7% formaldehyde in 
phosphate-buffered saline (PBS). CHD2 was detected by indirect immunofluorescent 
staining with polyclonal anti-Chd2 antibody (1:3000) followed by incubation with a 
fluorescein isothiocyanate-conjugated goat anti-rabbit immunoglobulin secondary 
antibody (1:500) (Jackson ImmunoResearch). Mounted slides were viewed with 
Axioplan microscope (Carl Zeiss Inc.) and images were captured with a high resolution 
charge-coupled device camera (Roper Industries). The images were analyzed using 
MetaMorph software (MDS Analytical Technologies). 
 
Western blot analysis to confirm specificity of anti-Chd2 antibody  
U2OS cells at 90% confluency were transfected with the expression plasmid 
construct containing 1395 amino acid Chd2 recombinant peptide with the tandem 
affinity (TAP) tag (ChdkthRR). Whole cell lysates were prepared using cold TAP lysis 
buffer (50mM Tris pH 8.0, 150mM NaCl, 0.1% NP-40, 10 mM β-mercaptoethanol, 50 
μg/ml avidin, 50mM NaH2PO4, and 10mM imidazole and protease inhibitors). The cell 
lysates were sonicated for 20 seconds in ice. The sonicated lysates were spiked with 
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3mM MgSO4 and 1mM CaCl2 and treated with 1μl of 50units/µl of micrococcal nuclease 
for 20 min at room temperature. Protein concentrations were determined using a BCA 
kit (Pierce). The lysates were eluted via AcTEV digest (3x 80U; Invitrogen) for 30min at 
37°C.  Straight lysates and TEV elutes were subjected to SDS-PAGE and 
immunoblotted with 1:1000 dilution of rabbit anti-6X His tag (Rockland) antibody and 
rabbit anti-Chd2 antibody (1:4000). 
 
Results and Discussion 
 
1.1 Analysis of expression pattern of mouse Chd2 transcript 
Chd2 was first characterized by Woodage et al in 1997 [31]. The authors [31] 
mapped the human CHD2 to the 15q26 region of chromosome 15 by PCR screening of 
the Genebridge4 RH mapping panel and showed the presence of an 11kb Chd2 
transcript in different tissues by northern blot. In skeletal muscle the northern blot 
revealed an extra 7.5-kb band as well as the 11-kb band [31]. To determine the 
expression pattern of mouse Chd2 in different mouse tissues, total RNA was isolated 
from each tissue and treated with DNase I, and subjected to RT-PCR amplification with 
Chd2 or RPL38 primers. The gene encoding the ribosomal proteinL38 (Rpl38) served 
as the internal control. The highest Chd2 expression was seen in the thymus, whereas 
liver and testis showed the least amount of Chd2 transcript expression (Fig.3) 
 
1.2 Polyclonal antibody production and immuno-localization of CHD2 
Protein sequence analysis of Chd2 shows the presence of four putative nuclear 
localization signals. Thus, to further localize Chd2 protein expression in the cell, we 
generated a polyclonal rabbit antibody against Chd2. Histidine-Chd2 fusion protein 
encoding the first 183 amino acids of Chd2 was produced and used to immunize the 
rabbits. The serum obtained from the rabbits was tested for its specificity by Western 
blot analysis with histidine tagged recombinant Chd2 protein expressed in U2OS cells 
(Fig.4). To investigate the localization pattern of CHD2 in cells, indirect 
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immunofluroscence technique was utilized. As shown in figure 5, anti-Chd2 
immunoreactivity is predominantly seen in the nucleus of the U2OS cells. 
1.3 Mouse models of Chd2 
In order to study the biological effect and role of CHD2, Chd2 mutant mice were 
generated by our laboratory using the Baygenomics genetrap ES cell resource [108]. 
The gene trap was shown to be inserted within intron 27 upstream of the A+T hook and 
three of the four putative nuclear localization signals. Analysis of the mutant mice 
indicated that the mutation of Chd2 lead to neonatal lethality in homozygous mice and 
enhanced lymphoma formation in heterozygous mice [110]. The study of growth kinetics 
on MEFs (mouse embryonic fibroblasts), derived from embryos obtained by crosses of 
Chd2 heterozygous males and females, shows low growth potential of mutant MEFs 
compared to wild type. In addition, an aberrant DNA damage response in Chd2 mutant 
cells was noticed. [109]. 
 
 
 
 
 
 
 
 
 
 
Total RNA isolated from each tissue was treated with DNase I and subjected to RT-
PCR amplification with Chd2 or Rpl38 primers. No products (Chd2/RPL38) were seen 
when total RNA in the absence of reverse transcription was subjected to PCR 
amplification (RT-). B.M refers to bone marrow. The internal control Rpl38 refers to the 
ribosomal protein L38 
 
 
 
Figure 3. Distribution of Wt-Chd2 transcript in mouse tissues. 
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The anti-Chd2 Ab could specifically recognize the recombinant Chd2 protein (1395 a.a) 
stably expressed in U2OScells (RR-3).  Note the anti-Chd2 Ab also showed 
immunoreactivity with cell lysates treated with TEV protease to cleave the histidine tag 
(TEV elute). The anti-6XHis Ab showed no immunoreactivity with the TEV elutes, further 
supporting the specificity of the Chd2 Ab. 
 
 
 
 
 
 
 
 
 
 
 
 
Indirect immunofluorescence using the anti-Chd2 antibody and a FITC conjugated 
secondary antibody shows localization of CHD2 to the nucleus 
 
Figure 4.Specificity of anti-Chd2 Ab 
Figure 5.Immunofluorescent localization of CHD2 in U2OS cells 
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The C-terminal Chd2 mutant mouse model retains a substantial portion of the 
protein and has a truncation of the last 583 amino acids of the 1827 amino acid long 
wild type protein. One caveat relating to the C-terminal mutant mouse model we 
developed initially is the fact that it retains a substantial portion of the protein even 
though it has a truncation of 583 amino acids at the C-terminus.  This brings about a 
possibility that the Chd2 mutant protein (fused to the β-galactosidase-neomycin fusion 
gene) may sequester additional transcription/DNA repair factors in to a non-functional 
complex or have dominant negative or gain of function effects leading to the observed 
phenotypes.  To test the possibility of dominant negative effects of the fusion peptide, 
we analyzed the inter-molecular interactions between recombinant Chd2 peptides that 
contained 6x-His and HA epitope tags.  Reciprocal immuno-precipitation analysis of 
recombinant Chd2 peptides showed that they were able to interact with each other (data 
not shown).  These results suggested that the Chd2-β-gal-neomycin fusion protein may 
either sequester the wild type Chd2 protein to the cytoplasm or compete with the native 
protein for its binding partners. 
Therefore, to rule out any indirect or dominant-negative effects of the mutant protein, a 
N-terminal mutant mouse model that is defective in the expression of 95% of the protein 
was generated. An N-terminal gene trapped ES cell line with the gene trap shown to be 
inserted in the intron 1 was identified (Fig.6). This insertion results in truncation of the 
protein after the first 20 amino acids.  The homozygous C-terminal Chd2 mutant mouse 
model was designated as Chd2 m/m and the N-terminal was designated as NChd2m/m.  
From a total of 9 chimeric mice (7 males and 2 females) generated from the Chd2 
mutant ES cells, three males were determined to be germ line chimeras. Heterozygous 
intercrosses aimed at generating homozygous mutants indicated that there was partial 
lethality in the heterozygous and nullizygous mutants (Table 1).  More importantly, 
unlike the C-terminal mutant mouse model, a fourth of the nullizygous NChd2 animals 
(NChd2m/m) survived at weaning (Table 1, last column). These results indicate the C-
terminal gene trap mutant exhibits a more drastic phenotype that is possibly due to 
dominant-negative function effects of the Chd2-beta-galactosidase fusion gene product.    
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The gene trap vector, composed of a part of the engrailed 2 intron 2 (en2 intron2), a 
splice acceptor (SA), a beta-galactosidase/neomycin resistance fusion cDNA (β-geo), 
an SV40 polyadenylation signal (SV40pA),(A) was inserted between exons 27 and 28 of 
the Chd2 gene for the C-terminal model,(B) between exons 1 and exons 2 for the N-
terminal model. 
 
 
 
 
 
 
Figure 6.Gene traps vector insertion in the Chd2 gene 
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Further analysis of NChd2 heterozygous mice (NChd2+/m) indicated that the loss of a 
single copy of the Chd2 gene leads to a decrease in the lifespan of the mice. 
Histological analysis of the tissues obtained from moribund NChd2+/m mice showed 
that they were succumbing primarily to lymphomas and the incidence of the lymphomas 
was higher than the incidence observed in the C-terminal mutant mice.  
While the lymphoma, lymphoid hyperplasia, and extra medullary hematopoiesis 
phenotypes were retained in the N-terminal mutant, there was significant reduction in 
the nephropathy and heart inflammation phenotypes indicating tissue specific 
differences in a subset of the phenotypes between the two mouse models. Furthermore, 
the N-terminal mutants exhibited an increase in the incidence of other tumor types 
(sarcomas and adenomas, 16.6% versus 5%) in comparison to the C-terminal mutants 
(Table-2). Animals were monitored for tumors, morbidity, or spontaneous death over a 
period of 120 weeks. Of the 30 animals analyzed for each group, all of the heterozygous 
mutants died in comparison to 10 deaths for the wild-type controls. The median lifespan 
of the NChd2+/m mice was 59.35 weeks in comparison to 91.3 weeks in the wild type 
littermate controls. All mice were of mixed in-bred C57BL/6X129/Sv background.  
 
1.4 Analysis of Chd2 expression in the N-terminal mutants 
NChd2+/+, NChd2+/m, and NChd2m/m mouse embryonic fibroblast cells lines 
(MEFs) were derived from embryos obtained from crosses of NChd2 heterozygous 
males and females. In order to quantify the wild-type and the mutant transcript in the 
homozygous mutant MEFs, real time RT-PCR was performed. NChd2m/m MEFs 
showed a reduced expression of about ~9% of the wild-type transcript (Fig.7). 
 
Significance of the study 
ATP-dependent chromatin remodeling proteins are known to be involved in the 
regulation of gene expression, recombination, replication and chromatin remodeling via 
their chromatin specific interactions and activities [17, 22]. These protein factors also 
play a part in the process of DNA repair, a role which has been increasingly recognized 
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for these factors. Some of the well documented examples include the role of ATP-
utilizing chromatin assembly and remodeling factor (ACF) in the repair of 6-4PD(6-4 
photoproducts) lesions on the DNA[111] and the interaction of INO80 with DNA damage 
induced phosphorylated histone H2A (γ-H2AX) [28, 30].   
Deregulation of DNA repair is known to contribute to genomic instability and tumor 
formation [16, 112]. Interestingly, now there are numerous reports which link the 
alterations in the ATP-dependent chromatin remodeling proteins to the development of 
cancer.  For example mutations in SNF5, BRG1 or BRM have been associated with the 
development of tumors [113].  Recently, somatic heterozygous missense mutations and 
promoter methylation of CHD5 were observed in some ovarian cancers [72]. In our 
study Chd2 mutant mouse model studies, we have shown that mutation in one copy of 
Chd2 results in enhanced lymphoma formation and reduced life span [110]. The 
emerging evidence supporting the role of ATP-dependent chromatin remodeling 
proteins in genomic instability and tumorigenesis along with our phenotypic 
observations of the Chd2 mutant mice has led us to hypothesize that the Chd2 
protein is involved in maintaining genomic stability via its involvement in DNA 
Damage responses. 
The following three chapters of this thesis describe the three main objectives 
proposed to prove the aforesaid hypothesis. The first objective is to determine whether 
Chd2 plays any role in the process of DNA damage response. Experiments were 
conducted to determine if loss of Chd2 increased the susceptibility of cells to DNA 
damage and genomic instability. 
The second objective involves the analysis of DNA damage induced post-
translational modifications within the CHD2 protein.  Protein phosphorylation is one of 
the commonly occurring post-translational modifications known to play a key role in 
DNA damage response.  Phosphorylation of proteins allow their timely activation to 
respond to the DNA damage signal [114]. 
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Table-1: Lethality of N-terminal Chd2 mutant mice. A total of 83 offspring were 
analyzed from 17 intercrosses.  The genotype analysis of the offspring obtained from F1 
intercrosses were performed using Chd2 specific primers in PCR assays. 
 
 
 
 
 
 
 
 
 
 
 
Table-2: Distribution of pathological conditions in Chd2 mutant (N-terminal 
mutant) mice.  Tissues from a total of 30 mice (NChd2+/m) were analyzed to determine 
the reasons for morbidity. 
 
Pathological Conditions Percentage affected  
Lymphoma  53%  (16 of 30)  
Lymphoid hyperplasia  36.6%  (11 of 30)  
Extra Medullary Hematopoiesis (EMH)  56.6%  (17 of 30)  
Glomerulo-nephropathy 10%  (2 of 19)  
Inflammation of heart/artery 11%  (1 of 9)  
Other cancers 16.6%    (5 of 30)  
 
 
 
Intercross 
 
NChd2 
+/+ 
NChd2 
+/m 
NChd2 
m/m 
Het.♂ X Het.♀  
 
36 39 10 
Expected Medelian 
ratio 
1 2 1 
Observed Mendelian 
ratio 
1 1.08 0.27 
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Each bar represents the relative Chd2 mRNA level in NChd2 (m/m) mutant MEFs 
compared with wild-type NChd2 (+/+) MEF after normalization to RPL38. The wild-type 
Chd2 transcript was detected in MEFs by RT-PCR using primers for exons 33-34. 
 
ATM (ataxia telangiectasia-mutated) and ATR (ATM and Rad3-related) are 
members of the phosphatidylinositol 3-kinase (PI-3) superfamily and are activated in 
response to DNA damage. Activated ATM /ATR phosphorylate many proteins, all of 
which have a role in DNA damage response pathway [115].  Analysis of the protein 
sequence of mouse Chd2 showed the presence of ten SQ (serine residue that precede 
glutamine residue) motifs. These motifs are potential sites for ATM/ATR mediated 
phosphorlyation, thus opening the gates of speculation that CHD2 would be a good 
substrate candidate for ATM/ATR mediated phosphorylation. Thus the second objective 
of the study was to test whether CHD2 is phosphorlyated after DNA damage and 
whether this phosphorlyation is brought about by ATM/ATR kinases. 
The third objective focuses on the identification of CHD2 interacting proteins in 
response to DNA damage.  DNA damage triggers the activation of phosphoinositide 3-
kinase-related kinases (PIKK).  Activated PIKK phosphorylates and activates H2AX, 
Figure 7.Analysis of NChd2 mRNA transcripts by real-time quantitative RT-
PCR using the 2-∆ ∆Ct method 
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checkpoint kinases (CHK1, CHK2), p53, MDM2, and BRCA1. All of these activated 
proteins then mediate the DNA damage response pathway (DDR) [116].  The tumor 
suppressor protein- p53 plays a crucial role in the signaling cascade known as the “DNA 
damage response (DDR)”. Activated p53 stimulates the transcription of target genes 
required for cell growth arrest as well as for efficient DNA repair. If the damage is 
unrepairable , p53 activates transcription of target genes involved in apoptosis[117]. 
Interestingly, ATP-dependent chromatin remodelers such as the SWI/SNF complex and 
CHD8 have been shown to interact with p53 and regulate the expression of p53 
dependent target genes [89, 118]. Our preliminary analysis of Chd2 deficient 
thymocytes shows that these cells are defective in their ability to induce the p53-
dependent pro-apoptotic gene, PUMA (George Samaan and Venkatachalam, 
unpublished observations).  Thus we seek to determine whether CHD2 interacts with 
p53 and regulates the transcription of p53 dependent target genes in the third objective 
of this study. In addition to that, we want to determine whether CHD2 interacts with any 
other DNA damage response proteins through a tandem affinity purification approach 
coupled with mass spectrometry analysis.   
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Chapter III 
Analysis of genomic stability and DNA repair process in Chd2 mutant 
cells 
Introduction 
DNA in living cells is subjected to damage everyday from both endogenous and 
exogenous sources. About 10,000 DNA lesions occur every day due to normal 
metabolic processes and environmental factors [119]. It is imperative that these lesions 
be corrected quickly and efficiently in order to prevent deleterious mutations, genomic 
instability or cell death. The DNA repair machinery complex in the cell thus forms the 
most vital component involved in the repair of these deleterious lesions.  Discrete 
biochemical DNA repair pathways exist in prokaryotes and eukaryotes to prevent the 
fixation of DNA damage in to heritable mutations. These repair pathways are divided 
into various subclasses based on the type of DNA lesion they repair. The major repair 
pathways include 1) the direct reversal pathway, (2) the mismatch repair (MMR) 
pathway, (3) the nucleotide excision repair(NER) pathway, (4) the base excision repair 
(BER) pathway, (5) the homologous recombination (HR) pathway, and (6) the non-
homologous end joining (NHEJ) pathway [120].  
 
The direct reversal pathway 
Alkylating agents such as N-methyl-N-nitrosourea or N-ethyl-N-nitrosourea react 
with bases to transfer methyl or ethyl groups to a guanine, forming alkylation products 
such as O6-alkylguanine. This modified guanine base does not pair up with cytosine 
properly during DNA replication causing G: C → A: T mutations by anomalous base 
pairing[121]. O6-alkylguanine adducts are removed through the direct reversal pathway 
by the enzyme O6-methylguanine-DNA methyltransferase (MGMT) in mammals and the 
enzyme Ada in Escherichia coli (E. coli). Both enzymes transfer the alkyl group from the 
oxygen in the DNA to a cysteine residue in its active site enabling the removal of the 
adduct [120].  AlkB, a dioxygenase present in E. coli is involved in the direct reversal 
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repair of 1-methyladenine (1meA) and 3-methylcytosine (3meC). Mammalian AlkB 
homologues, ABH2 and ABH3 are also shown to have similar repair properties [120]. 
 
The mismatch repair (MMR) pathway 
This repair pathway is activated in response to the presence of mismatched 
nucleotides/ DNA insertion-deletion loops formed due to DNA replication errors [121-
122]. The error rate occurring during this process is approximately 107 per bp per 
genome [122].  The different proteins involved in the MMR pathway present in E.coli 
include MutS, MutL, MutH, γ-δ Complex, β-Clamp, Helicase II, ExoI, ExoX, RecJ, 
ExoVII, DNA pol III, SSB and DNA ligase. Homologs of the E.coli MMR proteins have 
been recognized in the eukaryotic system also. These different proteins in the pathway 
perform different tasks such as recognition of the mismatch, excision of the mismatch, 
DNA resynthesis and gap filling with the newly synthesized DNA [122]. A defective 
MMR pathway results in the instability of the genome at microsatellite regions consisting 
of mono- and di-nucleotide repeats. Hereditary non-polyposis colorectral cancer is the 
most common disease that arises from a defective MMR pathway in humans [123]. 
 
The nucleotide excision repair (NER) pathway 
NER is a complex multistep DNA repair process involved in the repair of DNA 
lesions caused by UV radiation, mutagenic chemicals, or chemotherapeutic drugs that 
form bulky DNA adducts. About 30 mammalian proteins and 3 prokaryotic proteins have 
been identified as key players of the NER pathway [124-125]. Two types of NER 
pathways are the global genome NER (GG-NER) and the transcription-coupled NER 
(TC-NER).  The XPC–RAD23B and DDB1–DDB2/XPE proteins detect lesions in the 
GG-NER pathway whereas the cockayne syndrome group A (CSA) (ERCC8) and CSB 
(ERCC6) proteins mediate the recognition in the TC-NER pathway [120, 126].  GG-NER 
detects and removes lesions throughout the genome whereas TC-NER repairs only 
actively transcribed genes [120]. The NER pathway involves recognition of the DNA 
lesion, dual incision of the damaged site by the incision complex (RPA [replication 
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protein A], XPA [xeroderma pigmentosum, complementation group A], XPG, and 
XPF/ERCC1), lesion removal, gap filling, and ligation by RPA, RFC [replication factor C 
small subunit], PCNA [proliferating cell nuclear antigen], DNA polδ and ε, and DNA 
ligase I [121]. Xeroderma pigmentosum (XP), Cockayne syndrome (CS), and 
trichothiodystrophy (TTD) are three common syndromes associated with defective NER 
[126]. 
 
The base excision repair (BER) pathway 
DNA base damage occurring primarily from oxidative processes is repaired via the 
BER pathway. The two sub-pathways, short-patch BER and long-patch BER, involve 
removal of the damaged base by the enzyme DNA glycosylase leading to generation of 
an apurinic or apyrimidinic (AP) site [121, 127].  The AP site is removed by the 
endonuclease APE1. The short-patch BER pathway replaces a single nucleotide in the 
AP site and is mediated by DNA polymerase-β (Polβ). The long-patch BER pathway 
replaces 2-13 damaged nucleotides with the help of Polβ and/or Polε or δ. Nucleotide 
replacement is followed by strand ligation performed by the XRCC1/ligase III (LigIII) 
complex.  Defective functioning of the glycosylase MUTYH results in G: C→T: A 
mutations leading to MUTYH-associated polyposis (MAP), an autosomal recessive 
disorder characterized by multiple colorectal adenomas and carcinomas [120]. 
 
The homologous recombination (HR) pathway 
DNA double strand breaks (DSBs) are considered one of the most serious forms of 
DNA damage caused by exposure to ionizing radiation (IR), chemotherapeutic drugs, 
reactive oxygen species, and mechanical stress. Physiological DSBs also arise due to 
rearrangements of the immunoglobin loci in B cells, the rearrangement of the T-cell 
receptor loci in T cells, and during meiotic recombination [112, 128].  Repair of double 
strand breaks occur via the homologous recombination and the non-homologous end-
joining (NHEJ) pathways [129]. 
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The initial step of the homologous recombination (HR) pathway begins with the 3‟ 
DSB end processing by the NBS1/MRE11/RAD50 complex. This is followed by binding 
of RAD51-BRCA2 complex to 3‟ single-strand DNA. The RAD51 complex facilitates the 
invasion of 3‟ single-strand DNA into the homologous DNA double duplex which is then 
followed by strand extension by DNA polymerase. The resulting DNA crossovers called 
„Holliday junctions‟ are subsequently resolved resulting in error-free DNA DSB repair 
[121, 130]. DNA DSBs occurring in germline tissues and those occurring during S and 
G2 phases of the cell cycle are repaired mainly by the HR pathway [121]. Defects in the 
HR pathway is associated with increased cell death, cell-cycle arrest, telomere defects, 
genomic instability, meiotic defects, immunodeficiency, and cancer [120].  
 
The non-homologous end joining (NHEJ) pathway 
The NHEJ pathway mainly acts to repair damaged DNA during the G1 phase of the 
cell cycle in somatic cells. It involves joining the broken ends of the DNA ,sometimes 
resulting in loss/gain of nucleotides and thus is error prone [131].  The process involves 
a complex interplay of various enzymes and proteins. The Ku70/80 heterodimer protein 
complex binds to the ends of the damaged DNA promoting the recruitment of the DNA-
dependent protein kinase catalytic subunit (DNA-PKCS) to the DSB. DNA-PKCS 
phosphorylates many DNA repair proteins and recruits them to the damaged site. The 
repaired DNA ends are then ligated by the ligase IV/XRCC4 complex [132-133].  
Mutations in the key players of NHEJ pathway result in increased chromosomal 
instability, increased cell death, cell-cycle arrest and increased incidence of tumors. 
Examples of disorders associated NHEJ repair pathway include Nijmegen Breakage 
syndrome (NBS) and Ataxia Telangiectasia-like disorder (ATLD) [121].  
 
Chromatin remodeling and DNA repair 
Compact nucleoprotein organization denies access to various regulatory factors 
involved in processes such as DNA-replication, -recombination, -repair, and -
transcription. Histone modifying and chromatin remodeling complexes help to loosen up 
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the chromatin, giving passage to the regulatory factors to act on the naked DNA.  ATP-
dependent chromatin remodelers such as the Swi2/Snf2 related ATPase are key 
players in the DNA repair process [111, 134]. These chromatin remodelers alter the 
chromatin structure either through nucleosome displacement or histone exchange, 
increasing the access to the DNA lesion. For example, the ATP-utilizing chromatin 
assembly and remodeling factor (ACF), moves the nucleosomes, enhancing the activity 
of NER proteins to repair 6-4PD(6-4 photoproducts) lesions on the DNA [111]. 
The yeast SNF2-related ATPase complex, INO80, is another commonly studied 
ATP-dependent chromatin remodeling factor that aids in DNA repair. The complex 
contains 15 subunits which includes Swi2/Snf2-like ATPase subunit Ino80 and two 
proteins related to the bacterial RuvB DNA helicase [135]. The INO80 complex is 
recruited to the DSB at the yeast MAT (mating-type) locus induced by the homothallic 
switching (HO) endonuclease [136]. Mutations in genes encoding the ATPase subunits 
of the INO80 complex result in sensitivity to hydroxyurea, methyl methane sulfonate 
(MMS), UV and ionizing radiation, highlighting the role of the chromatin remodeler in 
DNA repair [135].  INO80 interacts with DNA damage induced phosphorylated histone 
H2A (γ-H2AX) at the DSB site further proving its important contribution to the DNA 
repair pathway [30].  The yeast RSC complex is also recruited to the DSB at the MAT 
locus along with the MRX (Mre11/Rad50/Xrs2) complex. The MRX complex then repairs 
the broken ends through the NHEJ pathway[111]. TIP60 possess both ATPase and 
histone acetyltransferase activity. TIP60 functions paradoxically in DNA repair pathway, 
first it acetylates histone H4 at the DSB acting as a signal for recruitment of HR repair 
proteins and second it catalyzes the exchange of phosphorylated histone H2Av for 
unmodified H2Av to cease the DSB signal after the completion of the repair process 
[137]. 
Swi2/Snf2 related ATPase containing SWR1 is another chromatin remodeler 
involved in histone exchange. SWR1 exchanges H2A-H2B dimers in nucleosomal 
arrays for H2AZ-H2B dimers. The presence of H2AZ histones loosen up the chromatin, 
increasing the accessibility to the DNA template. Yeast Swr1 null mutants are sensitive 
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to DNA damaging agents, highlighting the role of SWR1 in the DNA repair process 
[111].  The Swi2/Snf2-related Rad54 protein is a key player in the HR repair pathway. 
Rad54 helps recruitment of Rad51 to the 3‟ single-stranded DNA and later aids in the 
branch migration of the Holliday junction [138]. A study trying to elucidate the role of the 
SWI/SNF complex in DSB repair showed increased binding of the SWI/SNF complex to 
chromatin upon DNA damage. Cells with inactive SWI/SNF complex showed decreased 
induction of γ-H2AX and inefficient DSB repair after DNA damage. Further analysis 
showed interaction of the SWI/SNF complex with γ-H2AX, suggesting a role of the 
SWI/SNF complex in DSB repair pathway [139]. 
 
Chromodomain helicase DNA binding proteins and DNA repair 
There is no concrete evidence showing an association of CHD proteins with DNA 
repair processes. But there are some related studies which provide a clue to the 
involvement of CHD proteins in the DNA damage response pathway. One of the earlier 
studies done while trying to clone the SNF2/SWI2 helicase-related genes from the 
fission yeast Schizosaccharomyces pombe showed that the Hrp1+ gene (helicase-
related gene from S. pombe) exhibited a lower transcription rate upon treatment with 
DNA damaging agents such as MMS, MNNG, and UV. Protein sequence analysis of 
Hrp1 suggested that Hrp1 is a S. pombe homolog of mouse Chd1 [140].  A cDNA 
microarray study identified CHD6 as up-regulated after 0.5 Gy of gamma-ray irradiation 
in AHH-1 lymphoblastoid cells as well as in A549 cells and HeLa cells. The induction of 
CHD6 mRNA was dose-dependent and time dependent. CHD6 transcript levels 
increased up to 8hrs after treatment with low dose (0.5, 1 & 2Gy) irradiation and 
decreased after 12hrs. In addition, high doses (4 & 8Gy) of radiation did not increase 
CHD6 levels. Silencing of CHD6 in the cells increased the resistance of A549 cells to 
low dose radiation whereas radiosensitivity was unchanged in response to doses larger 
than 4 Gy suggesting a mechanistic role of CHD6 in cellular responses to low dose 
radiation [141]. Ataxia telangiectasia mutated (ATM) and Rad3-related (ATR) proteins 
belong to a family of phosphatidylinositolkinase (PIK)-related kinases that play an 
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important role in the detection of DNA damage and activation of DNA repair pathway. 
Co-immunoprecipitation studies showed association of ATR, CHD4, and HDAC2 
(histone deacetylase-2) in Hela cell lysates [142]. 
The limited literature evidence supporting the role of chromatin remodeling proteins 
in DNA repair process and the lymphoma phenotype seen in the Chd2 mutant mice 
prompted us to examine the role of Chd2 in the repair of DNA damage and maintaining 
genomic stability.  In this section we provide evidence that the Chd2 protein is required 
for maintaining genomic stability and for efficient repair of DNA damage.  Results from 
the metaphase analysis, comet assay and the clonogenicity assay show that the Chd2 
mutation renders cells susceptible to genomic instability and inefficient DNA repair.  
 
Material and Methods 
 
Generation of Chd2 mouse embryonic fibroblast cells (MEFs)  
MEFs were derived from 13.5-day-old NChd2+/+, NChd2+/m and NChd2m/m 
embryos. After removal of the head and intestinal organs, each embryo was washed 
with PBS and minced using 18 gauge needles. Cells were cultured in Dulbecco‟s 
modified Eagle medium with high glucose (HyClone, South Logan, Utah, USA) 
supplemented with 2mM L-glutamine, 1X antibiotic-antimycotic, 1μl/ml of fungizone 
(Invitrogen, Carlsbad, CA) , and 15% heat-inactivated fetal bovine serum (Gibco). 
Primary cells were frozen in aliquots after the first passage. 
 
Immortalization of Chd2 MEFs 
NChd2+/+, NChd2+/m and NChd2m/m cells were immortalized by transforming the 
cells with SV-40 (simian vacuolating virus 40) large T antigen containing plasmid 
pBSSVD2005 (gift from Dr. David Ron, Skirball Institute of Biomolecular Medicine).  
PrimaryNChd2 passage 1 MEFs were plated at 50% confluency in a 100mm plate and 
cells were transiently transfected with pBSSVD2005 using Lipofectamine 2000 reagent 
(Invitrogen, Carlsbad, CA) according to the manufacturer‟s instructions.  When the cells 
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were just confluent, they were split at a dilution of 1/10. The cells were continued to be 
split at 1:10 dilutions till passage 5. This type of splitting ensured a strong negative 
selection against non-transformed cells.  
 
Strand break detection using the alkaline comet assay 
Low passage NChd2+/+, NChd2+/m, and NChd2m/m MEFs were seeded in 60mm 
dishes 1 day prior to treatment with 4Gy radiation, such that they were 75-80% 
confluent on the day of the treatment . 2X105 cells were harvested at 10min, 30min, and 
120mins post treatment. Cells were also harvested from untreated controls. DNA 
damage was determined by single cell gel electrophoresis performed under alkaline 
conditions using the comet assay kit (Trevigen, Gaithersburg, MD) according to the 
manufacturer's instructions. Dried samples stained with SYBR Green I was imaged by 
epifluorescence microscopy. At least 100 nuclei per experiment were quantified and the 
amount of DNA damage present in the individual nuclei was measured by Olive tail 
moment [tail length X (tail fluorescence / (head + tail fluorescence)], using CometScore 
(http://www.autocomet.com/). At least two independent clones of MEF cell lines were 
analyzed for the assay. For UV-C treatment, growth media was removed from the cells, 
rinsed with PBS and were irradiated with UV-C light at a dose rate of 0.60J/m2 per 
second. Thereafter, growth media was added to the cells and incubated for the 
appropriate time periods. 2X105 cells were harvested at 1hr, 2hrs, 4hrs and 6hrs post 
treatment and comet assay was performed.  
 
Analysis of metaphase chromosomes 
Wild-type, heterozygous and homozygous NChd2 MEFs (1X 106) were seeded in a 
100mm plate a day before the experiment. The next day, actively growing cells were 
treated with 500ng (0.0625µg/ml) demecolcine (colcemid) to arrest the dividing cells in 
the metaphase. After 3 hr incubation with the colcemid, cells were trypsinized and 
collected as a pellet.  The cell pellet was treated with 5ml of hypotonic solution (3:1 
mixture of 0.566%potassium chloride and 0.8% sodium citrate) at 37°C for 15 minutes. 
  
42 
 
Following 15 min hypotonic treatment, cells were fixed in methanol: glacial acetic acid 
(3:1). Subsequently the cell suspension was dropped onto a microscope slide, and 
chromosomes were visualized with a light microscope after staining with Giemsa 
solution.  Fifty metaphase spreads per genotype were scored for numerical as well as 
structural chromosome abnormalities.  
Tumors derived from spontaneous thymic and spleenic lymphomas of male and 
female heterozygous NChd2 mice were characterized for chromosomal abnormality. To 
characterize the chromosomal abnormality associated with these lymphomas, single-
cell suspensions were prepared from hyperplastic spleens and thymus and the cells 
were resuspended in Dulbecco‟s modified Eagle medium with high glucose (HyClone, 
South Logan, Utah) supplemented with 2mM L-glutamine, 1X antibiotic-antimycotic, 
1μl/ml of fungizone (Invitrogen, Carlsbad, CA) , 10% heat-inactivated fetal bovine serum 
(Invitrogen), and 20μM β-mercaptoethanol [143]. Metaphase preparations were done 
according to the protocol provided by Dr. Bassing‟s laboratory. Briefly, 5ml of freshly 
isolated lymphoma cells were cultured for 2hrs at 370C in the presence of 25μl of 
colcemid (KaryoMax, Invitrogen) and 25μl of 2.8mg/ml BrdU (in HBSS). Cells were then 
transferred to a room temperature hypotonic solution (40.2mM KCl, 0.5373mM 
EDTA.Na2 and18.44mM HEPES.Na) for 25min at 37
0C and fixed by two changes of 
cold 3:1 methanol-acetic acid. Metaphase chromosome preparations were adhered to 
slides and sent to Dr. Bassing‟s laboratory for further processing for spectral 
karyotyping (SKY) analysis. 
 
MTT assay 
For the MTT [3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide; ATCC, 
Manassas, VA] assay, low passage NChd2+/+, NChd2+/m and NChd2m/m MEFs were 
placed in a 96-well plate at 6000 cells/well 1day prior to UV, X-ray and MMS treatment.  
The cells were left untreated or treated with the addition of 0.025% MMS and 0.05% 
MMS or exposed to 10 & 20 J/m2 UV radiation or to 5, 10, 15 and 20Gy dose of X-ray 
radiation. After 48hrs of culture, cells were treated with 10μl of MTT for 3hrs at 37°C, 
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allowing metabolic transformation of the MTT by the mitochondria and subsequent 
formation of an intracellular purple formazan. After solubilization of this precipitate, the 
absorbance was measured at 570 nm. Experiments were performed in quadruplets and 
results were normalized to control levels. At least two independent clones of MEF cell 
lines were analyzed for the assay.  
 
Clonogenicity assay  
SV-40 immortalized NChd2+/+, NChd2+/m and NChd2m/m(1X103) cells were 
seeded in complete media and treated with 10 & 20 J/m2 UV radiation or exposed to 2 & 
4 Gy dose of X-ray radiation after 24hrs. After ~10-12 days, the plates were stained with 
coomassie blue and colonies were counted using a stereomicroscope. The colonies 
from the various treatments were normalized to the control. For each treatment, the cells 
were plated in four 60mm2 plates. The whole experiment was repeated three times.  
 
Statistical analysis  
Data was analyzed using GraphPad software (La Jolla,CA).  Statistical significance 
was found using student‟s t-test and a P value < 0.05 was considered to be statistically 
significant.  
 
Results  
 
3.1. Chd2 mutant cells are inefficient in repair of IR induced DNA damage. 
The susceptibility of Chd2 heterozygous mutant mice to lymphomas and the 
accumulation of high levels of γH2AX after DNA damage in Chd2 mutant cells lead us 
to hypothesize that Chd2 is involved in DNA damage responses [109].   To test if the 
Chd2 mutant cells are defective in their ability to repair DNA damage, we performed 
alkaline single-cell agarose gel electrophoresis (comet assay) with NChd2+/+, 
NChd2+/m, and NChd2m/m MEFs to quantify DNA damage after exposure to X-ray 
radiation (IR) and UV radiation.  Cells from all three genotypes showed an extended 
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migration of fragmented DNA in comet tails after 10 min of exposure to 4Gy X-ray 
radiation. Interestingly, wild-type Chd2 cells exhibited a recovery from DNA damage 
after 2 hours of IR exposure, with the comet tail moment comparable to that of the 
untreated controls. However the heterozygous and the homozygous mutant Chd2 MEFs 
showed an inefficient DNA repair with the migration of fragmented DNA in comet tails 
still remaining higher even by 2 hours post exposure (Fig.8). Representative comet 
images of wild-type, heterozygous and homozygous Chd2 mutant MEFs obtained at 
different time intervals after exposure to 4Gy of X-ray radiation are shown in figure-9.   
To analyze the UV induced DNA damage response of Chd2 cells, NChd2+/+, 
NChd2+/m, and NChd2m/m MEFs were exposed to varying doses of UV-C and 
harvested 6 hrs later for comet assay. As shown in figure-10A, NChd2+/m and 
NChd2m/m cells accumulated significantly increased amounts of DNA damage with 
increasing UV doses, as compared to wild-type cells. To assess the repair kinetics of 
UV induced damage a time course experiment was performed.  As shown in figure-10B, 
1hr after UV-C exposure NChd2+/+, NChd2+/m and NChd2m/m MEFs displayed 
increased OTM (Olive Tail Moment). Analysis of data collected at subsequent time 
points post UV-C exposure showed that OTM of heterozygous cells and homozygous 
mutant remained greater than that for wild-type at all exposure times. In contrast to the 
heterozygous and homozygous mutant cells, the wild-type cells showed a recovery from 
DNA damage with OTM significantly decreasing 6 hrs post-incubation periods.   
 
3.2. Mutation in Chd2 promotes chromosomal instability. 
Genetic instability refers “to a range of genetic alterations from point mutations to 
chromosome rearrangements” [144]. Instability results from replication errors, defective 
DNA repair or error-prone translesion DNA synthesis [144]. Because Chd2 mutant cells 
showed inefficient DNA repair, we wanted to examine the genomic stability of these 
cells. Metaphase spreads were prepared from low passage wild type, heterozygous and 
homozygous mutant MEFs treated with 4gy X-ray radiation. The metaphases were 
stained with Giemsa stain and scored for numerical and structural abnormities. 
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To analyze the repair of DNA damage, alkaline single-cell gel electrophoresis (SCGE, 
comet assay) was performed. (A) Wild-type (+/+), heterozygous mutant (+/m) and 
homozygous mutant (m/m) MEFs were exposed to 4Gy X-ray radiation and harvested 
at 10, 30 and 120minutes. At least 100 nuclei per experiment were quantified and the 
amount of DNA damage present in the individual nuclei was measured by Olive tail 
moment (OTM).  OTM was calculated using the following formula: OTM=Tail length X 
(tail fluorescence / (head + tail fluorescence)]. (B) Percentage repair was evaluated by 
normalizing to OTM obtained after 10min exposure. Data 100 cells for each time point 
±SD are shown for (A). *, p = < 0.0001(wild-type versus heterozygote; wild-type versus 
homozygote). 
Figure 8.Role of Chd2 in repair of DNA damage 
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 DNA damage (tail moment) detected by the Comet assay at 0 (untreated), 10 min, and   
120 min in NChd2 MEFs treated with 4Gy X-ray radiation 
 
Of the 50 metaphases examined for each genotype, heterozygous and homozygous 
NChd2 MEFs showed a slight increase in aneuploid cells and chromosome aberration 
in comparison with wild-type cells, but the increase was not statistically significant 
(Fig.11A).  After X-ray treatment the heterozygous NChd2 MEF cells showed a 
significant increase in chromosomal aberrations including chromosome breaks, 
chromatid breaks, fragments, and ring chromosomes when compared to the wild-type 
cells (Fig.11B, Fig.12). These results further suggest that Chd2 protein plays a critical 
role in maintaining genomic stability.  
 
3.3. Metaphase analysis of spleenic and thymic lymphomas obtained from 
heterozygous mice. 
Cancer results from the accumulation of a number of genetic changes. These 
changes include mutation as well as chromosomal aberrations.  
 
Figure 9.Chd2 mutant cells have an impaired ability to repair damaged 
DNA 
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To analyze repair of DNA damage, alkaline single-cell gel electrophoresis (SCGE, 
comet assay) was performed. (A) Wild-type (+/+), heterozygous mutant (+/m) and 
Homozygous mutant (m/m) MEFs were exposed to different UV-C doses and harvested 
after 6 h. * p = 0.0088 (wild-type versus heterozygote); ** p = 0.0016 (wild-type versus 
homozygote).  (B) Cells were exposed to 10 J/m2 and subjected to SCGE after 
incubation times of 1, 2, 4 and 6 h. * p = < 0.0001 (wild-type versus heterozygote; wild-
type versus homozygote).  Data (OTM = Olive tail moment) of 100 cells for each time 
point & dose ±SD are shown. 
 
Figure 10.Repair of DNA damage induced by UV 
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Metaphase spreads from wild-type (+/+), heterozygous mutant (+/m) and homozygous 
mutant (m/m) Chd2 MEFs were scored for structural chromosomal abnormities [A] and 
numerical abnormality [B] (50 metaphases scored).   
 
Figure 11.Role of Chd2 in genomic stability 
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Representative photographs of metaphases from heterozygous mutant NChd2 MEF 
(+/m) and wild-type NChd2 MEF (+/+) showing chromosomal aberrations. 
 
A number of chromosomal aberrations have been associated with different types of 
cancers, for example translocation between chromosome 8 and 14 is associated with 
Burkitt‟s lymphoma [145]. Thus in an effort to understand the molecular basis of the 
spleenic and thymic lymphomas seen in heterozygous NChd2 mutant mice, metaphase 
spreads were made from these lymphomas and analyzed by spectral karyotyping. 
Eleven thymic lymphomas and eight spleenic lymphomas were obtained from 
heterozygous mice. Metaphase spreads were prepared from single cell suspensions of 
the lymphoma cells and sent for spectral karyotyping. Analysis of three thymic 
lymphomas showed presence of an extra chromosome 15 in two samples (data not 
shown). 
 
3.4. Mutation in Chd2 does not affect cell viability after DNA damage. 
Defective DNA repair and genomic instability usually results either in apoptosis or 
growth arrest. Thus to determine the viability of Chd2 mutant cells, an MTT (3-(4, 5-
Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) assay was performed with low 
passage NChd2+/+, NChd2+/m and NChd2m/m MEFs. Cell survival was determined 48 
Figure 12. Mutation in Chd2 promotes chromosomal instability 
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hours later and expressed as a percentage by setting corresponding untreated controls 
as 100%. There were no differences in the viability of NChd2+/+, NChd2+/m and 
NChd2m/m MEFs after exposure to various doses of X-ray radiation. Interesting, the 
NChd2+/m cells showed a slight but significant increase in viability with 20Gy of X-ray 
radiation (Fig.13).  
Treatment with UV did not show much difference in the viability between the wild-
type and heterozygous cells. However the heterozygous MEFs showed slightly 
decreased viability at higher doses of UV radiation (Fig.14). And interestingly as seen in 
figure 15, homozygous NChd2 mutant cells were significantly sensitive to both doses of 
UV radiation. To further determine the viability of Chd2 mutant cells in response to DNA 
damage by the alkylating agent, methyl methanesulfonate (MMS), we analyzed cell 
viability in wild type and Chd2 mutant cells. Homozygous mutant NChd2 cells exhibited 
a slightly reduced viability with both concentration of MMS treatment, whereas the 
heterozygous mutant cells exhibited reduced viability only with the higher concentration 
(0.05%) of MMS (Fig.15). However the difference was not statistically significant.  
 
3.5. Clonogenic survival of SV40 immortalized Chd2 MEFs is affected after DNA 
damage.  
The transformation of normal cells into tumorigenic cells requires several genetic 
events. The analysis of short term survival studies in primary mouse embryonic 
fibroblasts provide limited information on the role of proteins in cellular responses to 
DNA damage, thus a long term survival assay (clonogenicity assay) was performed with 
the Chd2 mutant cells.  To further investigate the role of Chd2 in affecting the 
clonogenic survival of cells, we used SV40 large T-antigen immortalized NChd2+/+, 
NChd2+/m, and NChd2m/m MEFs to examine their ability to survive DNA damage 
induction.  The large T-antigen induces the transformation of primary rodent cells by 
interacting and inactivating the tumor suppressor proteins p53 and Rb [146]. We 
performed clonogenic survival assays with SV40 transformed Chd2 proficient and 
mutant cells that were treated with UV and X-ray radiation. 
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MTT assay of NChd2+/+, NChd2+/m and NChd2m/m MEFs following exposure to 5, 10, 
15 and 20Gy dose of X-rays. Experiments were performed in quadruplets and results 
are normalized to control levels. Error bars represent SD values; ● p = 0.0161(wild-type 
versus heterozygote).  
 
 
 
 
 
 
Figure 13.Cell viability of Chd2 MEFs after X-ray induced DNA damage 
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MTT assay of NChd2+/+, NChd2+/m and NChd2m/m MEFs following exposure to 10 
and 20J/m2 of UV radiation. Experiments were performed in quadruplets and results are 
normalized to control levels. Error bars represent SD values; ■ p= 0.0198 (wild-type 
versus heterozygote); × p < 0.0001 (wild-type versus homozygote). 
 
 
 
 
 
 
 
 
 
 
 
Figure 14.Cell viability of Chd2 MEFs after UV induced DNA damage 
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MTT assay performed with NChd2+/+, NChd2+/m and NChd2m/m MEFs following 
exposure to 0.025 % & 0.05% MMS. Experiments were performed in quadruplets and 
results are normalized to control levels. Error bars represent SD values; *p = 
0.0127(wild-type versus heterozygote); ** p = 0.0163, (wild-type versus homozygote). 
 
As shown in figure-16, SV40 immortalized NChd2+/m and NChd2m/m MEFs showed 
marked hypersensitivity to UV treatment compared to the wild-type. However the 
clonogenic survival of SV40 immortalized NChd2+/m MEFs was not affected with lower 
doses (2Gy) of X-ray radiation. But with an increased dose of 4Gy X-ray radiation, 
NChd2+/m MEFs became more sensitive than their wild-type counterparts. These 
observations indicate that immortalization of the heterozygous and homozygous mutant 
Chd2 cell renders them susceptible to DNA damage induced by UV and X-ray, reducing 
their clonogenic survival.  
 
Discussion  
The data presented here demonstrate a potential role for Chd2 in maintaining 
genomic stability by affecting the efficiency of DNA repair. 
Figure 15. Cell viability of Chd2 MEFs after DNA damage with MMS 
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SV40 transformed wild-type (+/+) and Heterozygous (+/m) and homozygous (m/m) 
MEFs were seeded and treated with 10 & 20 J/m2 UV radiation or exposed to 2 & 4 Gy 
dose of IR. Colonies were counted after 7-10 days. The percentage of untreated cells 
was set at 100%. Error bars represent SD values for quadruplet‟s samples. * p = 
<0.0001(wild-type versus heterozygote; wild-type versus homozygote). 
 
It has been well established that when cells fail to repair or inefficiently repair DNA 
damage it leads to cell death or chromosomal instability. The resultant chromosomal 
rearrangements or mutations contribute to tumorigenesis [147-148]. 
The NChd2+/m MEF displayed a delayed response to removal of DNA damage, as 
these cells showed high accumulation of DNA in their comet tail 2 hours post X-ray 
treatment and 6 hours post UV treatment. This finding was further supported by the 
observation that NChd2+/m MEFs showed a significant increase in chromosomal 
damage after exposure to X-ray radiation. However it was of interest to note that the 
short term viability of the NChd2+/m was not affected by the accumulated DNA damage. 
NChd2+/m MEFs were slightly more resistant to cytotoxicity by X-ray radiation, low 
doses of UV, and low concentrations of MMS than NChd2+/+ cells. It has been reported 
Figure 16. Clonogenicity assay of Chd2 MEFs 
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that measuring cell death using short-term viability assays such as the MTT assay is not 
an accurate measure to determine the role of DNA damage responses [149]. These 
assays have been shown to miscalculate the overall level of cell killing as cell death can 
take hours or days depending upon the cell type and the genotoxic agent used [149]. It 
has also been shown that primary mouse or human fibroblast cells are relatively more 
resistant to damage induced apoptosis [149-150].   
The homozygous mutant cells demonstrated a decrease in the efficacy of DNA-
repair in response to X-ray and UV radiations, but interestingly, they did not display 
extensive chromosomal instability post-crisis as the heterozygous mutant cells in 
metaphase analysis. This difference in observations between the NChd2m/m and 
NChd2+/m MEFs indicates that the loss of function of Chd2 due to mutation in both the 
copies of the gene may be compensated by another member of the same family (for 
example Chd1). This phenomenon known as functional compensation is not uncommon 
and has previously been reported in many studies [151-153].  In addition, the 
differences in the cell cycle phase of the homozygous mutant cells compared to the 
heterozygous mutant cells may be a reason for the reduced genomic instability in the 
homozygous cells. There are several reports which demonstrate that cells show a 
differential degree of sensitivity to DNA damage based on the phase of the cell cycle 
they are in [154-155]. The metaphase analysis of the wild type and Chd2 mutant cell 
lines were performed using asynchronous cells as synchronization of primary wild type 
MEFs leads to a substantial portion of the MEFs to arrest in the G0 phase of the cell 
cycle.  Therefore the reduced chromosomal stability of the homozygous mutant is 
possibly related to differences in the cell cycle phase differences of the homozygous 
mutants in comparison to wild type and heterozygous mutant cells.     
A direct correlation between Chd2 mutation and aberrant DNA damage response 
was observed with SV-40 immortalized NChd2+/+, NChd2+/m and NChd2m/m MEFs. 
The colony forming capacity of the NChd2m/m and NChd2+/m MEFs was significantly 
compromised after treatment with DNA damaging agents.  While, several studies have 
reported that presence of SV-40 large T-antigen in cells renders them more susceptible 
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to DNA damage [156-157].  The significant differences between the SV-40 transformed 
wild type, NChd2m/m and NChd2+/m MEFs after treatment with DNA damaging agents 
suggest that the Chd2 protein functions in DNA repair pathways. 
It has been shown that ATP-dependent chromatin remodeling proteins like INO80 
and SWR1 complexes perform critical functions in DNA repair by directly binding to the 
sites of DNA DSBs through their association with γ-H2AX. They bring about 
“nucleosome eviction” to facilitate the recruitment of DNA repair proteins and cell cycle 
check point proteins [158].  Other chromatin remodeling proteins like SWR1 are 
involved in the exchange of H2A-H2B dimers in nucleosomal arrays for H2AZ-H2B 
dimers. The presence of H2AZ histones loosen up the chromatin, increasing the 
accessibility to the DNA template. ATP-dependent chromatin remodeling proteins are 
not only required during the repair process but are also needed upon completion of the 
process to restore the native chromatin structure. The TIP60 histone acetyltransferase 
that also possesses ATPase activity, is known to catalyze the exchange of 
phosphorylated histone H2Av for unmodified H2Av to cease the DSB signal after the 
completion of the repair process [137]. TIP60 is also involved in regulation of DNA 
damaged induced acetylation of H2AX. Following DSB formation, TIP60 acetylates 
H2AX which results in the recruitment of the ubiquitin-conjugating enzyme UBC13. 
UBC13 promotes polyubiquitination of H2AX resulting in the release of H2AX from 
damaged chromatin [159]. Recently a haploinsufficient tumor suppressor gene, HINT1, 
which codes for a histidine triad nucleotide binding protein was shown to participate in 
ionizing radiation (IR) – induced DNA damage responses. HINT1 deficient cells 
exhibited an inability to displace γ-H2AX subsequent to DNA repair which was 
associated with impaired acetylation of γ-H2AX [160]. HINT1 deficient cells also showed 
inefficient DNA repair due to impaired acetylation of ATM [160].  It is of interest to note 
that, we have previously shown that Chd2 mutant cells fail to remove γ-H2AX after DNA 
repair [109].  These results in conjunction with the defective repair phenotypes of the 
Chd2 mutant cells suggest that CHD2 is potentially involved in facilitating acetylation of 
γ-H2AX  once the repair process is complete , thus helping in restoration of the 
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chromatin structure. Alternatively CHD2 may function to remodel chromatin during the 
repair process by facilitating access to DNA repair proteins to sites of DNA damage. 
Additional studies to determine the functional binding partners of CHD2 would provide 
further insights into CHD2‟s function in the DDR pathway.  
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Chapter IV 
Determination of molecular changes in CHD2 in response to DNA 
damage 
Introduction 
The DNA damage response (DDR) triggered by the cell consists of several 
interconnected pathways that include DNA repair, cell cycle arrest, and cell death. A 
variety of events in DDR are initiated through activating signals transmitted by 
checkpoint transducers. The transducers and their downstream targets are activated by 
different posttranslational modification events, such as phosphorylation, acetylation, 
methylation, and ubiquitylation, which influence their activity [161-162]. Central 
components of the kinase pathway are the phosphoinositide 3-kinase related kinases 
ATM, ATR, and DNA-PK.  ATM (ataxia telangiectasia-mutated) and ATR (ATM and 
Rad3-related) are members of the phosphatidylinositol 3-kinase (PI-3) superfamily that 
are activated in response to DNA damage. Other members of the family include 
ATX/SMG-1, mTOR (mammalian target of rapamycin), FRAP (FK506binding protein 12-
rapamycin associated protein 1), and DNA-PKcs (DNA-dependent protein kinase). 
Members of the PI-3 superfamily contain the PI3 kinase domain which is the catalytic 
site of the active protein kinase responsible for phosphorylating the key proteins 
involved in DNA damage response [116]. ATM and DNA-PK respond to DNA double 
strand breaks caused by ionizing irradiation (IR), while ATR and ATX respond to UV or 
stalled replication forks [14].  Studies have shown that the MRN complex is first 
recruited to the site of DSB and activates ATM by facilitating stable binding of ATM to its 
substrates and also promoting ATM‟s auto-phosphorylation [163]. The C-terminus of 
ATM harbors the FAT (FRAP/ATM/TRAP) domain, a PI3 kinase domain, and the FATC 
(FAT C-terminal) domain, all which regulate the kinase activity of ATM [164].   
ATM exists as a dimer in its inactive state; upon sensing DSBs it undergoes auto-
phosphorylation at serine 367, serine 1893, and serine 1981 residues leading to 
formation of active ATM monomers [164].  The ATM and ATR kinases, once activated, 
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phosphorylate H2AX, CHK2, CHK1 kinase, p53, MDM2, BRCA1, which then mediate 
downstream DDR [116]. Phosphosrylation of H2AX at serine 136 and 139 by ATM/ATR 
occurs within minutes of DNA double strand break (DSB) induction.  Many additional 
substrates of ATM such as Rad17, p95, BRCA2, PTS, PhasI, WRN, DNA-5B and ligase 
IV have been identified  and have been shown to play a role in DNA damage response 
pathway [115]. Consensus target sequences of ATM and ATR phosphorylation have 
been characterized which act as guidelines to determine whether a protein sequence is 
a potential target for phosphorylation by ATM/ATR kinase. These are: a) the presence 
of SQ/TQ motifs (serine or tyrosine residue that precede glutamine residue), b) the 
presence of hydrophobic amino acids at positions N-3 and N-1, and c) the presence of 
atleast three SQ/TQ motifs in a “core region of 100 amino acids” [115, 165]. Mutations 
in the ATM gene results in an autosomal recessive disorder known as Ataxia-
telangiectasia (AT), characterized by cerebellar ataxia, telangiectasia, 
immunodeficiency, hypersensitivity to radiation induced cancers, defective cell cycle 
checkpoints, and chromosomal instability [164]. 
 
ATM/ATR and Chromatin remodeling proteins 
It has been well established that the remodeling of chromatin takes place in the 
presence of DSBs and that this remodeling is necessary for efficient recruitment of DNA 
damage response proteins to the DSB site [166]. The decondensation of the chromatin 
takes place via an energy dependent manner suggesting that the initial sensors of 
DSBs have an ATP-dependent remodeling property [167]. The relaxation of chromatin 
is further enhanced by phosphorlyated H2AX (γ-H2AX) and ATM. Both of these proteins 
are involved in initiating the DNA damage response signal and recruitment of ATP-
dependent remodeling complexes [167-168]. This fact is further supported by 
experimental evidence showing that ATM negative cells exhibit inefficient histone loss 
from the DSB site [168]. Furthermore, a study in yeast showed that the yeast Mec1/Tel1 
kinases (ATM/ATR in mammals) phosphorylated the Ies4 subunit of the ATP-dependent 
remodeling protein complex-INO80 when the yeast cells were exposed to DNA 
  
60 
 
damaging agents. Phosphorylation of les4 influenced the checkpoint response following 
DNA damage. Additionally, the Mec1/Tel1 kinase phosphorylated H2AX, which then 
promoted the recruitment of INO80 to the region of DNA damage [169]. KAP-1(KRAB-
associated protein), a corepressor of gene transcription, was shown to be an ATM 
effector protein. KAP-1 was phosphorylated by ATM upon DSB induction. 
Phosphorylated KAP-1 spreads throughout the chromatin and facilitates chromatin 
decondensation [170]. KAP-1 recruits heterochromatin protein 1(HP1) to histones. It 
also associates with the histone methyltransferase SETDB1 and Mi2-α. Assembly of 
these proteins coordinated by KAP-1 results in heterochromatization [171].  Protein 
interaction studies with ATM reveled its association with the histone deacetylase 
HDAC1, and the interaction was shown to increase with exposure to ionizing radiation 
[172]. A more recent study showed association of ATR with CHD4 and HDAC2 (histone 
deacetylase-2) in Hela cell lysates [142].  These studies demonstrate the functional 
importance of ATM/ATR dependent activation of ATP-dependent chromatin remodeling 
proteins in DNA damage responses.  
In this section we show that CHD2 is a novel substrate of the ATM/ATR kinases. 
Analysis of the CHD2 protein sequence shows the presence of ten SQ motifs out which 
one motif has a hydrophobic amino acid at N-3 and N-1 and five motifs have a 
hydrophobic amino acid at either the N-3 or N-1 position.  The presence of these SQ 
motifs in the CHD2 protein make CHD2 a potential target for ATM/ATR mediated 
phosphorylation. The SQ motifs were indeed phosphorylated upon damage, seen by 
immunoblot analysis using anti-phospho-SQ motif antibody. Immunoprecipitation 
studies were also conducted to determine whether ATM/ATR physically interact with 
CHD2 to bring about its phosphorylation.  The findings of this objective and its biological 
relevance are discussed in this chapter.  
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Materials and Method 
 
Generation of polyclonal Chd2 antibodies 
Commercially available cDNA clones that contain various segments of Chd2 were 
used to generate an N-terminal portion of Chd2. cDNA fragment encoding the first 313 
amino acids of Chd2 were generated by restriction enzymes or PCR and then inserted 
into the Pet30A bacterial expression vector, which contains a histidine tag at the N-
terminus. Synthesis of fusion protein was induced for 24 hrs at 200C with 1mM 
isopropyl-β-D-thiogalatoside. His-Chd2 fusion protein was isolated by affinity 
chromatography on a nickel column. A single rabbit was immunized with a His-Chd2 
fusion protein encoding the first 183 amino acids of Chd2. The serum obtained from the 
rabbit was tested for its specificity against recombinant Chd2 peptides.  
In addition to the generation of a polyclonal antibody to the first 183 amino acids of 
the mouse Chd2 protein, we also generated antibodies against specific peptides within 
the N-terminal region of the Chd2 protein. Rabbit anti-Chd2 antibody was generated by 
Open Biosystems (Huntsville, AL) to Chd2 peptides corresponding to the amino acid 
“RSNRSRQEPSRFNIKEEA” and “KQPKTQRGKRKKQDSSDEDD” were synthesized 
along with a 5‟cystine and conjugating to KLH using the Maelimide kit (Pierce). 
  
Gel Electrophoresis and Immunoblots for detection of CHD2 
Normal human diploid fibroblasts- OSU2 cells were treated with 8Gy X-ray radiation 
and whole cell extracts were prepared by harvesting cells at 1, 1.5,3, and 5 hours. 
Whole cell extracts were prepared by resuspending cell pellets in 4X packed volume of 
lysis buffer (50mM Tris pH 8.0, 150mM NaCl, 0.1% NP-40, 10 mM β-mercaptoethanol, 
and 10% glycerol and protease inhibitors) and incubating on ice for 15 min. The cell 
lysates were sonicated for 10 seconds in ice. The sonicated lysates were spiked with 
3mM MgSO4 and 1mM CaCl2 and treated with 1μl of 50units/µl of micrococcal 
nuclease for 20 min at room temperature. Protein concentrations were determined using 
a BCA kit (Pierce). Western blot samples were then prepared by adding an equal 
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volume of 2× SDS-gel loading dye to the lysates and boiled for 3 minutes. The 
supernatant obtained was electrophoresed on an 8% SDS-polyacrylamide gel.  The 
samples were transferred onto a PVDF membrane overnight at 40C, 14 V.  The 
membrane was probed with rabbit anti- Chd2 primary antibody, 1: 5000 for 1.5 hours at 
room temperature followed by peroxidase conjugated mouse anti-rabbit light chain IgG, 
1: 3000 for 1 hour at room temperature.  The immunoblots were developed using 
chemiluminescence by the addition of Supersignal West Pico (Pierce). 
 
cDNA synthesis and reverse transcriptase (RT)- polymerase chain reaction (PCR) 
OSU2 cells were treated with 8Gy X-ray radiation and harvested at 1, 1.5,3, and 5 
hours after treatment. RNA was isolated from these cells by using TRIzol reagent 
(Invitrogen) according to the manufacturer's protocol. Genomic DNA was removed by 
incubating RNA samples with 2U of RNase-free deoxyribonuclease I (Promega) per 3µg 
of RNA for 30 minutes at 370C. First strand cDNA synthesis was performed with 3µg of 
total RNA using random hexamers and M-MLV reverse transcriptase (Promega).  As a 
negative control, samples containing RNA but no reverse transcriptase were also 
included.  2µl of cDNA was used for PCR. The primer sequences for Chd2 are: 
GGTGGTGATGGCAAGTCTTCAAGT (exon 33); AGGCAAATGAGGCTTCTGAGGATG 
(exon 36). The primer sequences for housekeeping gene ribosomal protein L38 
(RPL38) are: TTCGGTTCTCATCGCTGTGAGTGT (forward); 
TCTTGACAGACTTGGCATCCTTCC (reverse). The PCR conditions for Chd2 exons 33-
36 were initial denaturation at 940C for 2 min, followed by 30 cycles at:  940C for 30 sec, 
580C for 30 sec, and 720C for 40 sec with a final extension at 720C for 5 mins. The 
conditions for Rpl38 were 940C for 2 min, followed by 30 cycles at: 940C for 30 sec, 
580C for 30 sec, and 720C for 10 sec. PCR products were resolved by agarose gel 
electrophoresis and stained with ethidium bromide. 
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Generation of Chd2 with a hemagglutinin epitope tag (HA tag) at the c-terminus 
Chd2 cDNA encoding the first 1395 amino acids and first 447 amino acids were 
tagged with a HA tag at the c-terminus using the PCR /restriction enzyme based cloning 
strategy into the vector pSport6. The clones were designated as PChdKHACT and 
PChd1KHA respectively. The constructs were expressed in U2OS cells and expression 
efficiency of the construct was measured by performing western blot using anti-HA 
antibody. An Immunflourescence study was performed with 1:500 dilution of mouse 
anti-HA antibody (Covance) and 1:250 dilution of fluorescein conjugated anti-mouse IgG 
(Jackson ImmunoResearch) to assess the localization pattern of the construct. 
PChdKHACT stable cell lines were created by co-transfecting the Chd2 plasmid with a 
puromycin-resistant plasmid (kind gift from Dr.Yisong Wang, Oak Ridge National Lab). 
 
Generation and expression of Tandem affinity purification (TAP) tagged Chd2  
Tandem affinity purification (TAP) tags were added to Chd2 using the Gateway 
system. A cDNA fragment of Chd2 encoding the first 447 amino acids and the first 1395 
amino acids with flanking attB1 and attB2 was generated by restriction enzymes or 
PCR. Chd2 clones with flanking attB sites were recombined with a donor vector 
(pDONOR221) to create an entry clone. The entry clone was then recombined with a 
destination vector (pcDNA-DEST40) to create an expression clone of Chd2 with C-
terminal TAP tags (Chd1KSH and ChdkthRR respectively). Donor vector and modified 
pcDNA-DEST40-destination vectors were provided by Dr.Yisong Wang. The modified 
pcDNA-DEST40-destination vector contains the following tag at its c-terminus: 
2strep2tev6His. Stable cell lines for both Chd1KSH and ChdkthRR were created by co-
transfecting the Chd2 plasmids with a puromycin-resistant plasmid (kind gift from 
Dr.Yisong Wang, Oak Ridge National Lab). Expression efficiency and localization of the 
constructs were tested by immune blotting using rabbit anti-6X His tag (1:1000, 
Rockland) antibody and immunofluorescence using rabbit anti-Chd2 antibody (1:3000).  
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Transfection and Immunoprecipitation 
U2OS cells at 90% confluency were either transfected with control or the expression 
plasmid construct containing 1395 amino acid Chd2 recombinant peptide with the 
tandem affinity (TAP) tag (ChdkthRR). Forty-eight hours after transfection, the cells 
were treated with different DNA damaging agents – U.V rays (50 J – 30minutes, 
2hours), X-rays (40 Gy -30 minutes, 2 hours), and methyl methanesulfonate (MMS – 
0.01% - 30 minutes, 2 hours). The cells were harvested and whole cell lysates were 
prepared using the appropriate volume of lysis buffer (50mM Tris pH 8.0, 150mM NaCl, 
0.1% NP-40, 10 mM β-mercaptoethanol, 50mM NaH2PO4, and 10% glycerol and 
protease inhibitor). The lysates were sonicated for 10 seconds and spiked with 3mM 
MgSO4 and 1mM CaCl2, and then treated with 1μl of 50units/µl of micrococcal nuclease 
and 1μl of 2mg/ml of DNase for 20 min at room temperature. Total protein concentration 
was determined using a BCA protein assay kit (Pierce).  
For immunoprecipitation, 40μl of 50% slurry of Ni-NTA beads (IBA, St. Louis, MO) 
were washed with 100μl of Net gel buffer (50mM Tris pH 8.0, 0.1% NP-40,1mM EDTA 
and 0.25% gelatin), resuspended in 50μl of Net gel buffer and added to 200μg of 
lysates. Lysates were immunoprecipitated with rotation at 40C for 2hours.  The beads 
were washed with three times with 500μl of Net gel buffer. To examine the resulting 
protein complex, the beads were mixed with 1X SDS gel-loading dye (50mM Tris-Cl pH 
6.8, 100mM dithiothreitol, 2%SDS, 0.1% bromophenol blue, and 10% glycerol) and 
boiled for 5 min at 900C. The samples were centrifuged at 2000 rpm for 5 sec to pellet 
the beads and the supernatant was electrophoresed on an 8% Tris-Glycine gel. The 
samples were then transferred to a PVDF (Polyvinylidene Difluoride) membrane 
(Thermo scientific) using Tris-glycine transfer buffer containing 20% methanol (25mM 
Tris, 200mM glycine, 0.2% SDS, and 20% methanol).  
 
Immuno blot analysis of phosphorylated SQ/TQ motifs 
The PVDF membrane was washed 2X for 5 min in TBS/Tween (20mM Tris pH 7.4, 
0.15 M NaCl, and 0.1% Tween) and blocked for 1hour at room temperature with 5% 
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milk/TBS/Tween. For detection of phosphorylated SQ/TQ motifs, the PVDF blot was 
incubated with phosphorylated SQ/TQ motif antibody (Cell Signaling Technology) in a 
1:690 v/v dilution at 40C overnight. The dilution was done with 5% BSA in 1X TBS and 
0.1% Tween-20. Immunoblots were washed 3X with TBS/Tween followed by incubation 
with HRP-conjugated secondary antibody anti-rabbit (Pierce) in a 1: 2000 dilution v/v at 
room temperature for 1hour. The dilution of the secondary antibody was done with 5% 
milk/TBS/Tween. The blot was washed 3X for 15 min with TBS/Tween. The immunoblot 
was then subjected to chemiluminescence by the addition of Supersignal West Pico 
(Pierce), according to manufacturer‟s instructions, and exposed on CXS X-ray film 
(CXS, Omaha, NE).  
 
Co-immunoprecipitations of CHD2 and ATR from nuclear extracts 
75-80% confluent cultures of U2OS cells were treated with 10 and 20J/m2 doses of 
UV radiation.  Untreated and treated U2OS cells were washed with PBS and cells were 
collected by scraping. Nuclear pellets were obtained by lysing the cells with cytoplasmic 
buffer (10mM Tris HCl pH 7.9, 0.34M sucrose, 3mM CaCl2, 2mM Mg-Acetate, 0.1mM 
EDTA, and protease inhibitors) and by centrifugation at 3,500 X g for 15 min at 40C. 
Nuclei were lysed with modified lysis buffer (50mM Tris pH 7.5, 150mM NaCl, 1mM 
EDTA, 1% Triton X100, 3mM MgSO4, 1mM CaCl2, and 5% glycerol and protease 
inhibitor) followed by sonication.  The lysates were digested with 50units of micrococcal 
nuclease and 2μg of DNase for 20 min at room temperature.  Total protein 
concentration was determined using the BCA protein assay kit (Pierce).  400 µg of 
extracts were pre-cleared with 10µl of 50% slurry of protein A sepharose beads for 
20min at 40C. The pre-cleared extracts were then incubated with antibodies against 
ATR, Chd2 or with normal IgG for 4h at 40C. The protein complex was 
immunoprecipitated by incubating with 20µl of 50% slurry of protein A-sepharose beads 
overnight at 40C. The immunoprecipitated fractions were washed 3X with wash buffer 
(20mM HEPES pH 7.9, 150mM KCl, 0.5mM EDTA, 0.1% Triton X-100 and 10% 
glycerol). The washed fractions were subjected to SDS-PAGE and immunoblotting with 
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rabbit anti-Chd2 (1:20,000) or goat anti-ATR (1:500, Santa Cruz Biotechnology) 
antibodies were done. 
  
Results 
4.1. X-ray induced DNA damage increases endogenous CHD2 protein levels 
Many proteins are activated and stabilized rapidly after DNA damage. Post-
translational modifications of the DSB response/repair proteins facilitate damage-
specific interactions to enhance the repair process [173]. For example, induction of p53 
in response to DNA damage results in the up-regulation of its downstream targets (e.g. 
WAF1/p21, GADD45, cyclin G, Bax, and Mdm2) and leads to initiation of cell-cycle 
arrest or apoptosis [174]. To determine if DNA damage leads to changes in the stability 
of CHD2 protein levels experiments were performed with normal human diploid 
fibroblasts exposed to 8Gy X-ray radiation. CHD2 protein levels were examined at 
various time intervals using an anti-Chd2 antibody developed in our laboratory. CHD2 
protein expression reached its maximum by 1-3hours after X-ray exposure and then 
started to decline by 5 hours after exposure (Fig.17). 
 
4.1.1 Induction of CHD2 post DNA damage regulated by posttranslational events 
In order to determine whether the induction of CHD2 after DNA damage was due to 
post-translational modification or due to an increase in transcription, reverse 
transcriptase (RT) coupled PCR was performed using RNA isolated from untreated and 
X-ray treated cells. RT-PCR analysis of CHD2 expression in OSU2 cells after exposure 
to 8Gy dose of X-ray radiation at the indicated time intervals failed to show a 
concomitant elevation in CHD2 mRNA levels (Fig.18). This indicates that the X-ray 
triggered induction of CHD2 is regulated by posttranslational events. 
 
4.2. CHD2 is a potential ATM/ATR substrate 
The rapid activation and stabilization of DNA damage response proteins usually 
occurs via post-translational modifications that involve phosphorylation of specific 
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residues.  Earlier studies have shown that the ATM/ATR kinases phosphorylate a 
variety of proteins involved in the regulation of cell cycle responses induced by DNA 
damage [175-178].  ATM/ATR substrates have a common S/TQ (serine residue that 
precede glutamine residue) motif and the ATM/ATR kinase preferentially phosphorylate 
these motifs. The p53 tumor suppressor, BRCA1, and CHK2 are among the well known 
targets of ATM kinase to name a few [179-186]. 
While the role of ATM in signal transduction events leading to cell cycle arrest or 
apoptosis have been well established, its effect on the regulation of events (DNA repair 
as well as DNA-damage signaling) in the context of chromatin are not completely 
understood.  In an effort to determine if CHD2 is a substrate for ATM we analyzed the 
human CHD2 peptide sequence and found the presence of ten SQ sites and a single 
TQ site (QPKT197QR) within the protein.   
 
 
 
 
 
 
 
 
 
 
 
 
Cells extracts were prepared at the time points indicated after exposure to 8Gy X-ray 
radiation and processed for western blot analysis using Chd2 and actin antibodies. Actin 
levels show equal amount of protein loading. 
 
 
 
 
 
 
 
 
Figure 17.Induction of CHD2 in OSU2 cells following DNA damage 
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Upper panel: RT-PCR products of CHD2 expression (exons33-36) in OSU2 cells after 
exposure to 8Gy dose of X-ray radiation at the indicated time intervals. Lower panel: 
RT-PCR products of the internal control housekeeping gene RPL38. 
 
The relative locations of the SQ sites within the CHD2 sequence are shown in figures 
19A and B.  Among the ten SQ sites, four sites (S582, S814, S1019, and S1560) contain 
hydrophobic amino-acids either in the N-1 and N-3 which is indicative of a positive ATM 
substrate specificity [115, 165].  
 
4.3. Phosphorylation of CHD2 by ATM/ATR kinase in response to DNA damage 
To determine if CHD2 is phosphorylated after DNA damage, we expressed histidine 
tagged recombinant Chd2 encoding the first 1395 amino acids (ChdkthRR) in U2OS 
cells and analyzed the phosphorylation of 6X-His-Chd2 using an anti-phosho-(SQ/TQ) 
antibody (Cell Signaling Technology). As shown in figure 20A, X-ray and UV irradiation 
led to an increase in the phosphorylation of recombinant Chd2 (1-1395) indicated by the 
presence of an intense band around ~168kDa. 
Authenticity of the band was confirmed by stripping and reprobing the membrane with 
anti-6X His antibody, which showed a band around ~ 168kDa, the predicted size of the 
recombinant Chd2 peptide. Figure 20B shows the expression efficiency of the two Chd2 
recombinant constructs: Chd1KSH and ChdkthRR.  
Figure 18.Effect of X-ray treatment on CHD2 mRNA expression determined by 
RT-PCR 
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To further determine if ATM is involved in the phosphorylation of CHD2, we 
determined the phosphorylation status of CHD2 in AT proficient (U2OS) and deficient 
(AT) cells. AT cells are negative for ATM expression and thus serve as a control. U2OS 
and AT cells were transfected with HA-tagged clone of Chd2 plasmid (PChdKHACT). 
Localization of the construct was tested by immunofluorescence. As shown in Figure 
21, the recombinant HA-tagged Chd2 localized to the nucleus. The transfected cells 
were treated with 40Gy X-ray for 30 minutes. Straight cell lysates were immunoblotted 
using antibodies against phosphorylated SQ/TQ motif.  Western blot results showed a 
~168KDa band in U2OS cells transfected with Chd2, whereas no band was seen 
around the same region in Chd2 transfected AT cells (Fig.22). 
 
 
 
 
(A).The relative locations of the SQ sites within the Chd2 protein sequence are shown. 
(B).The sequences of SQ motifs present in Chd2 showing presence of a hydrophobic 
amino acid at either N-3 or N-1 position or a hydrophobic amino acid at both N-3 and N-
1 position. 
 
 
Figure 19.Potential ATM target sequences in Chd2 
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4.4. Physical interaction between ATR and CHD2 
ATP-dependent remodeling proteins have been identified as “novel and functional 
components in the ATM/ATR DNA damage checkpoint signaling pathway” [169].  For 
example the INO80 complex is a functional component in the Mec1/Tel1 kinase 
signaling pathway in yeast and CHD4 is part of the ATR- HDAC2 complex [142, 169].   
Thus, we sought to determine whether the endogenous ATR and CHD2 proteins can 
physically interact by co-immunoprecipitation. CHD2 was immunoprecipitated from 
treated (10J and 20J) and untreated (control) U2OS cells using an anti-Chd2 antibody 
bound to protein A beads. Western blot analysis with the anti-ATR antibody showed the 
presence of ATR in the CHD2 immunoprecipitated beads from U2OS cells treated with 
20J. Longer exposure showed a very faint band in control and in samples treated with 
10J. No ATR bands were seen when the immunoprecipitation was done with normal 
IgG bound to protein A beads (Fig.23A). The interaction between ATR and CHD2 was 
confirmed by a reciprocal immunoprecipitation.  Immunoblot analysis of CHD2 with the 
ATR immunoprecipitated beads showed a robust interaction of CHD2 with ATR in both 
control and U.V treated samples and this interaction increased in response to UV 
induced DNA damage (Fig.23B). 
 
Discussion 
The CHD family of proteins belong to the class of ATP-dependent chromatin-
remodeling factors [187]. The CHD proteins are characterized by the presence of the 
Swi2/Snf2-like helicase/ATPase domain and two chromodomains (chromatin 
organization modifier) [34].  These proteins have previously known to be involved in the 
regulation of gene expression as transcription activators or repressors [34]. Recently, 
there have been several studies where some of the members such as CHD8, CHD5, 
CHD7 and CHD1 of this family have been reported to be involved in other processes 
such as apoptosis, tumorigenesis, mammalian development, and maintaining 
centrosome integrity via their chromatin specific interactions and activities [64, 70, 83, 
89, 105, 188].  
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(A) CHD2 phosphorylation by ATM/ATR kinase(s). U2OS cells were transfected with 
TAP-tagged clone of Chd2 plasmids and treated with different DNA damaging agents – 
U.V rays (50 J – 30minutes), X-rays (40 Gy -30 minutes) and methyl methanesulfonate 
(MMS – 0.01% - 30 minutes). TAP tagged Chd2 was immunoprecipitated from cell 
lysate using Ni-NTA beads after 48 hours of transfection. The beads were washed and 
the immunoprecipitated CHD2 protein was analyzed by western blot. Western blot was 
performed to determine the phosphorylation of Chd2 by ATM/ATR kinase using 
antibody against phosphorylated SQ/TQ motif. The same membrane was reprobed for 
6X His tag (lower panel).  (B) Expression of Chd2 peptides containing tandem 
affinity tag.  Cell lysates were prepared from U2OS cell lines expressing the two Chd2 
recombinant peptides (lane 1: ChdkthRR, lane2: empty lane and lane 3: Chd1KSH)   
and analyzed by anti-6X His antibodies in western blot assays.  The molecular weight 
markers are indicated on the left. 
 
 
A 
B 
Figure 20.CHD2 is phosphoylated at the SQ site 
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Nuclear localization of recombinant Chd2 peptide. Detection of HA tagged Chd2 with 
anti-HA antibodies in transfected U2OS cells by immunofluorescence staining. 
 
 
 
 
 
 
 
 
 
 
 
 
 
U2OS/AT cells were transfected with HA-tagged Chd2 and treated with 40Gy X-ray 
radiation, lysed after 30 minutes and analyzed by immunoblotting with anti-phosho – 
(SQ/TQ) antibody. The membrane was reprobed for HA-tag (lower panel). 
 
 
 
 
Figure 21.Generation of recombinant HA tagged Chd2 peptide 
Figure 22. CHD2 phosphorylation by ATM/ATR 
kinase(s) 
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(A) Cell extracts from untreated and treated (10J-2hr & 20J-2hr) U2OS cells were 
immunoprecipitated (IP) with anti-Chd2 antibody or normal rabbit IgG and 
immunoblotted with anti-ATR antibody. (B) Reciprocal immunopreciptation was 
performed with anti-ATR antibody and the membrane probed with anti-Chd2 antibody.  
 
 
 
 
 
 
A 
B 
Figure 23. Interaction of CHD2 and ATR 
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These studies highlight the important role played by the CHD proteins in diverse 
nuclear processes.  Our studies were aimed at elucidating the role of CHD2 in DDR 
based on the following observations; (i) presence of putative ATM/ATR motifs in the 
Chd2 protein, ii) aberrant gamma-H2AX removal in Chd2 mutant cells, and (iii) the high 
lymphoma susceptibility of the Chd2 mutant mouse model generated in our laboratory 
to spontaneous lymphomas. The DNA damage response trigged by the cells is a 
complex pathway and the key coordinators are the ATM/ATR kinases. ATM and ATR 
belong to the phosphatidylinositol 3-kinase-like kinase (PIKK) family of protein kinases.  
These protein kinases are involved in phosphorlyation of crucial checkpoint signalling 
proteins and DNA repair proteins that activate the DNA repair response pathway [189]. 
Interestingly, the recent large-scale identification of ATM/ATR substrates in 293T cells 
indicates the presence of four CHD family members (CHD4, CHD5, CHD6, and CHD7) 
that are phosphorylated by ATM/ATR [190].  Furthermore, one of the CHD 
proteins,CHD4 has been reported to be an ATR-associated protein [142].  In addition, 
the S/TQ motifs are present in the subunits of many chromatin-modifying complexes 
such as SWI/SNF, RSC, and SWR1 [165, 169]. Additionally, two ATP-dependent 
chromatin remodeling proteins, Ies4 subunit of the INO80 complex and BAF170 subunit 
of the SWI–SNF complex have been reported to be phosphorylated by the ATM/ATR 
kinase in response to DNA damage [169, 191].  
In this study we show that CHD2 is a potential substrate for ATM/ATR kinases. 
Protein sequence analysis of Chd2 reveled presence of ten ATM/ATR consensus (S/T) 
Q motifs.  Immunoblot analysis indicated a specific band around 168 KDa with phospho-
S/TQ (p-S/TQ) antibody when cells expressing the recombinant Chd2 peptides were 
treated with 40Gy dose of X-ray radiation. However this band was not seen when the 
recombinant Chd2 peptides were expressed in the cells negative for ATM expression.  
This data provides evidence that ATM/ATR kinases mediate the phosphorylation of 
CHD2 in response to DNA damage. This post translational modification (PTM) of CHD2 
may help modulate its activity in response to DNA damage. Additionally, our 
immunoblot results show that CHD2 is stabilized in vivo in response to DNA damage. 
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There is a rapid induction of CHD2 protein levels after 3hours of DNA damage and the 
basal protein levels return 5hours post DNA damage. Furthermore, induction in CHD2 is 
mediated by posttranslational modifications as no difference was observed in the mRNA 
levels of the CHD2 gene in human cell lines. 
Our data also suggest that CHD2 interacts with ATR. The endogenous ATR and 
CHD2 co-precipitated efficiently, especially after DNA damage with 20J. However the 
amount of ATR detected in the CHD2 immunoprecipitates was low. This may be due the 
low abundance of ATR in the cells and also that CHD2 may be binding to only a small 
proportion of the ATR in UV treated cells. Similar observations were reported for the 
ATR and CHD4 molecular association study [142].  In addition to ATR, CHD2 may also 
possibly interact with ATM kinase. But since the immunoblot analysis with two different 
commercially available ATM antibodies did not work in our hands, further interaction 
studies with ATM were not pursued. 
The above results provide initial clues to the role of CHD2 in modulating DNA 
damage responses in mammalian cells. The phosphorylation status of CHD2 would 
facilitate direct interaction of CHD2 with checkpoint proteins or DNA repair proteins.  For 
instance, an enhanced interaction between the DNA response protein BRIT1 and SWI–
SNF in response to DNA damage has been reported.  This DNA-damage-enhanced 
binding affinity is mediated through an ATM/ATR-dependent phosphorylation of BAF170 
subunit of SWI-SNF complex [191]. Alternatively, it is also possible that CHD2 
phosphorylation status may activate its function as a chromatin remodeler by altering 
the chromatin environment surrounding DNA damage. The altered chromatin structure 
may facilitate rapid recruitment of checkpoint proteins or DNA repair proteins to the 
damaged site. Studies illustrating the effect of phosphorylation on the functions of 
chromatin remodeling proteins such as hSWI/SNF complex[192], dMi-2 chromatin 
remodeling complex [32] and INO80 complex [169] have been reported. In conclusion, 
the induction of CHD2 and its phosphorylation after DNA damage suggests a potential 
role for the protein in mediating DNA damage responses.  However, the effect of 
phosphorylation on CHD2 function remains to be ascertained. 
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Chapter V 
Determination of interaction of Chd2 with p53 and other proteins 
involved in genomic stability and DNA repair 
Introduction 
Chromatin remodelers alter the chromatin structure either through nucleosome 
displacement or histone exchange, increasing the access for the regulatory factors to 
perform various cellular processes. Various studies have shown the importance of 
chromatin remodeling for p53 to function as a transcription factor. Histone-modifying 
cofactors such as histone acetyltransferases- p300/CBP,  Histone deacetylases 
(HDAC), protein arginine methyltransferases -CARM1, and PRMT1 are known to be  
important for p53 to regulate the expression of  its target genes [193]. Studies have also 
provided links between p53 induced chromatin relaxation and DNA repair as part of the 
process of nucleotide excision repair. Treatment with UV irradiation resulted in 
recruitment of p300 and p53-dependent acetylation of lysine 9 of histone H3, leading to 
chromatin relaxation and efficient NER [194]. 
Persistent DNA damage and its erroneous resolution lead to genomic instability, 
tumorigenesis or cell death.  Cells respond to DNA damage by activating a “signaling 
cascade known as the DNA damage response (DDR)” [117]. The key player in this 
cascade is the tumor suppressor protein- p53.  p53 is a 53 kilodalton(Kda) 
nucleophosphoprotein which functions as a transcription factor [195]. The protein was 
identified in 1979 as SV40 large T antigen interacting peptide and postulated to be 
regulator of T-antigen functions [196]. Further elaborate studies designed to analyze the 
functions of p53 revealed its important role as a tumor suppressor [197].  The p53 
protein contains a sequence-specific DNA binding domain which interacts with specific 
target double-stranded DNA sequences made up of two copies of 5'-PuPuPu-
C(A/T)(T/A)GPyPyPy-3'separated by 0-13 nucleotide. A vast majority of p53 mutations 
which occur in human cancers involve this DNA binding region [195].  Physiologically 
altered stress conditions such as DNA damage, heat shock, hypoxia, hyperoxia, 
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cytokines, growth factors, metabolic changes and oncogenes increase p53 levels, which 
otherwise is expressed in very low levels [195]. Autoregulatory negative feedback loops 
ensure low levels of p53 under normal circumstance. Three ubiquitin ligases, MDM2, 
Pirh2 and Cop-1 are involved in ubiquitination of p53, which leads to proteasomal 
degradation [198]. The exposure to stress conditions leads to stabilization and 
activation of p53 via a series of post-translational modification, mainly phoshorylation 
and acetylation [179, 198-200]. 
Phosphorylation of p53 is brought by activated phosphoinositide 3-kinase-related 
kinases (PIKK) after DNA damage [116]. Histone acetylases, p300/CBP and PCAF 
bring about acetylation of p53 [198]. Activated p53 stimulates the transcription of target 
genes required for cell growth arrest as well as for efficient DNA repair. p53 brings 
about cell cycle arrest in the G1 and G2 phase via activation of genes p21CIP1/WAF1 and 
Gadd45, respectively [195]. If the damage is unrepairable then p53 activates 
transcription of target genes involved in apoptosis such as PUMA [p53 up-regulated 
modulator of apoptosis], NOXA [phorbol-12-myristate-13-acetate-induced protein 1 ] 
and BAX [BCL2-associated X protein] [117].  According to the International Agency for 
Research on Cancer TP53 database, about 24,785 somatic mutations and 423 germline 
mutations in the p53 gene have been associated with human cancers to date 
(http://www-p53.iarc.fr/). About 75% of these somatic mutations are missense 
substitutions, 9% are frameshift insertions and deletions, 7% nonsense mutations, 5% 
silent mutations and other infrequent alterations [201]. Early-onset cancers in Li-
Fraumeni (LFS) and Li-Fraumeni-like syndromes (LFL) result from p53 germline 
mutations [201].  
  Loss of proliferation control, an important characteristic of cancer cells, can arise 
due to aberrant cell cycle regulation and/or a reduced ability to undergo apoptosis. The 
spontaneous lymphoma susceptibility of the Chd2 mutant mice may underlie a defect in 
either cell cycle arrest and/or apoptosis due to a defective signal transduction at the 
chromatin level. Consistent with this, Chd2 mutant cells show an increased proliferation 
potential in comparison to wild type counterparts (data not shown).  In addition, 
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unpublished results from our lab show a defective induction of the pro-apoptotic gene 
Puma in Chd2 mutant thymocytes. These results suggest that the Chd2 mutant 
lymphoid cells may have a defective apoptotic response due to an aberrant p53 
response and a potential role for CHD2 in regulating the p53 transcriptional activity.  To 
address this possibility, we have performed studies to determine the interaction of 
CHD2 and p53. 
While the CHD2-p53 interaction studies provide evidence for the role of Chd2 in the 
regulation DNA damage induced transcriptional activation of stress response genes, the 
identity of the CHD2 basal complex remains to be determined. Furthermore, the 
biochemical purification of other CHD proteins has shown that the CHD3 and CHD4 
proteins are components of the NuRD complex while the yeast Chd1 protein co-purifies 
with the SAGA-SLIK complex in yeast [46, 57]. To identify CHD2 interacting proteins 
and its potential interaction with DNA damage response proteins (DNA repair and 
checkpoint proteins) and to understand the functional pathways regulated by CHD2, a 
tandem affinity purification approach coupled with mass spectrometry (MS) was 
performed for the identification of CHD2 interacting partners.  
In recent years, mass spectrometry is emerging as a valuable tool for identifying 
proteins present in large complexes. Affinity purification followed by mass spectrometry 
analysis of the protein complexes is the method of choice because of its high sensitivity 
and specificity [202]. Some common approaches used for protein complex isolation are 
affinity chromatography, immunoprecipitation, epitope-tagging, GST-pulldown and 
tandem affinity purification [202-203]. Approaches such as affinity chromatography, 
immunoprecipitation, epitope-tagging, and GST-pulldown usually generates high 
background, results in identification of cross-reactive contaminating proteins and failure 
to isolate low stoichiometry interacting partners. The method of dual purification- TAP-
tagging (tandem affinity purification) has been designed to overcome some of the 
aforementioned drawbacks. The TAP-tagging strategy makes use of a tag comprised of 
two affinity components with a protease cleavage site in-between the two components 
[204]. The original TAP tag consists of a calmodulin-binding peptide followed by a 
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tobacco etch virus (TEV) protease cleavage site and a IgG binding moiety of S.aureus 
protein A (Protein A) [204]. The TAP approach helps in efficient reduction of non-
specific background and isolation of protein complex under physiological conditions 
[202].  The basic steps of this approach are, fusing the protein of interest in-frame with 
an N- or C-terminal TAP tag, expressing the recombinant protein in a particular cell line 
and then isolating the protein of interest and its interacting partners via tandem affinity 
purification. Tandem affinity purification involves immunoprecipiting the complex first 
using Protein A- IgG sepharose beads and then isolating the protein of interest along 
with its binding partners by cleaving the complex using TEV protease. This process 
ensures that the proteins which bind to the resin non-specifically are not isolated along 
with the protein complex of interest. The protein complex of interest is further purified by 
immobilizing to calmodulin coated beads and eluting via calcium chelation [203, 205].  
The purified protein complex is separated via any of the following techniques, SDS-
PAGE, isoelectric focusing or other two-dimensional approaches. The proteins are then 
digested into shorter peptides with a proteolytic enzyme such as trypsin or Lys-C and 
separated using reversed-phase capillary liquid chromatography to be injected into the 
mass spectrometry via electrospray ionization [203, 206].  The mass/charge ratio of the 
peptides are measured and then subjected to collision-induced fragmentation to 
generate a tandem (MS/MS) mass spectrum.  The tandem mass spectra obtained are 
analyzed using computer algorithms such as SEQUEST or Mascot. The algorithm 
generates a theoretical fragmentation pattern for amino acid sequences in the database 
and matches to the observed tandem MS [206-207].  This method has lead to 
identification of the components of the important protein complexes from bacteria, 
yeast, plants and mammalian cells [205, 208-210].  In this study we have used a 
modified version of the original TAP tag, developed by Dr. Yisong Wang‟s laboratory, 
Oak Ridge National Laboratory. The modified version consists of a Strep-Tactin binding 
peptide followed by the TEV protease recognition site and then a 6X histidine (His) tag 
[210].  Dr. Wang‟s group has generated five dual-tag purification vectors, each with 
different sets of affinity tags. They have used these vectors to successfully identify 
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known interacting partners of human telomeric repeat binding factor 2(TRF2) protein 
[210].  The results described in this chapter includes, the list of CHD2 interacting 
proteins obtained from the mass spectrometric analysis done by Dr. Hayes McDonald 
(Oak Ridge National Laboratory) following the TAP purification protocol and the mass 
spectrometric analysis done by Applied Biomics following single step elution protocol. 
Materials and Methods 
 
Co-immunoprecipitations of CHD2 and p53 from whole cell lysate 
Identification of endogenous CHD2 and p53 interaction:  Actively growing culture of 
U2OS were irradiated with 10Gy dose of X-ray and harvested 2hrs later. Untreated and 
treated pelleted cells were resuspended in 4X packed volume of lysis buffer (50mM Tris 
pH 8.0, 150mM NaCl, 0.1% NP-40, 10 mM β-mercaptoethanol, and 10% glycerol and 
protease inhibitor) and incubated on ice for 15 min. The cell lysates were sonicated for 
10 seconds in ice. The sonicated lysates were spiked with 3mM MgSO4 and 1mM CaCl2 
and treated with 1μl of 50units/µl of micrococcal nuclease for 20 min at room 
temperature. Protein concentrations were determined using a BCA kit (Pierce).  300 µg 
of extracts were pre-cleared with 15µl of 50% slurry of protein A sepharose beads pre-
equilibrated with modified Net gel buffer (50mM Tris pH 8.0, 0.1% NP-40,1mM EDTA, 
0.25% gelatin, 2% BSA and protease inhibitors) for 20min at 40C.  The pre-cleared 
extracts were then incubated with an antibody against Chd2 overnight at 40C. The 
protein complex was immunoprecipitated by incubating with 30µl of 50% slurry of pre-
equilibrated protein A-sepharose beads at 40C for 2hrs. The immunoprecipitated 
fractions were washed 3X with Net gel buffer containing no BSA.  The washed fractions 
were subjected to SDS-PAGE and immunoblotted with 1:1200 dilution of anti-p53 
antibody [mouse monoclonal Ab-4(NeoMarkers)]. 
Identification of exogenous CHD2 and p53 interaction:  90% confluent culture of 
U2OS cells were either mock transfected (control) or co-transfected with the expression 
plasmid construct containing 1395 amino acid Chd2 recombinant peptide with HA tag at 
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the c-terminus (PChdKHACT) and/or with plasmid containing Flag tagged p53.  
PChdKHACT stable cell lines were also used for the experiment and were transfected 
with plasmid containing Flag tagged p53.  The following day, cells were treated with 
10Gy X-ray radiation and incubated for 2hrs. Extracts from transfected/untransfected 
U2OS and PChdKHACT stable cells were then prepared as described above. 200µg of 
the total protein extract was incubated with 5µl of 50% slurry of anti-HA affinity matrix 
(Roche) pre-equilibrated with modified Net gel buffer (50mM Tris pH 8.0, 0.1% NP-
40,1mM EDTA, 0.25% gelatin, 2% BSA and protease inhibitors) 40C overnight. The 
immunoprecipitated fractions were washed 3X with wash buffer (20mM Tris pH 8.0, 
100mM NaCl, and 0.05% Tween-20).  The washed fractions were subjected to SDS-
PAGE and immunoblotted with anti-p53 antibody, 1:1200 dilution [mouse monoclonal 
Ab-4(NeoMarkers)] and with 1:500 dilution of anti-HA-peroxidase high affinity rat 
monoclonal antibody (Roche).  
 
Generation of full length recombinant Chd2 
Chd2 cDNA encoding the last 432 amino acids was synthesized from thymus RNA 
obtained from a wild type mouse using Phusion® RT-PCR kit (NEB) according to 
manufacturer‟s protocol. The cDNA was amplified using a Pst1 restriction site 
containing forward primer and a reverse primer containing a Not1 restriction site and a 
FLAG tag sequence.  The purified PCR product was double digested with PstI and NotI 
(Roche, NEB) and cloned into PChdKHACT plasmid previously digested with PstI and 
Not1. The construct was recloned into a pcDNA 3.1 vector. This construct was named 
as “YP2”.  YP2 was expressed in U2OS cells and expression efficiency of the construct 
was tested by performing western blot using rat anti-FLAG antibody (1:4000) 
(BioLegend).  
 
Tandem affinity purification (TAP) of CHD2 protein complex 
Exponentially growing cells of RR3 (stable cell line expressing the first 1395 amino 
acid Chd2 recombinant peptide with the dual affinity tags (Strep-TEV-6XHis) and PDYM 
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(stable cell line established by transfecting with empty vector) were treated with different 
DNA damaging agents such as 10Gy IR-1hr, 10Gy IR-4hr and 10J U.V-4hrs and 
harvested after the indicated incubation time.  Untreated/control and treated cells were 
scraped and the cell pellets were resuspended in a 4X volume (of the cell pellet) of cold 
TAP lysis buffer (50mM Tris pH 8.0, 150mM NaCl, 0.1% NP-40, 10 mM β-
mercaptoethanol, 50 μg/ml avidin, 50mM NaH2PO4, 10mM imidazole and protease 
inhibitors) . The cell lysates were sonicated for 20 seconds in ice. The sonicated lysates 
were spiked with 3mM MgSO4 and 1mM CaCl2 and treated with 1μl of 50units/µl of 
micrococcal nuclease for 20 min at room temperature. Protein concentrations were 
determined using a BCA kit (Pierce).  TAP purification were performed as described by 
Giannone et al. [210] with some modification. Ten milligram of total protein extract was 
incubated for 1 h at 4°C under gentle rotation with 25µl of solid Ni-NTA beads (Qiagen), 
pre-equilibrated with 500µl wash buffer-I (50 mM Tris, 50 mM NaH2PO4, 150 mM NaCl, 
40 mM imidazole, 1 mM DTT and 0.1% NP-40, pH 8). The supernatant was reapplied to 
25µl of fresh pre-equilibrated solid Ni-NTA beads and rotated for 1h at 4°C.  The beads 
were transferred to 15ml falcon tube and washed three times with 5 ml of wash buffer-I 
and once with 4ml of TEV cleavage buffer(TCB: 50 mM Tris, 150 mM NaCl, 0.5 mM 
EDTA, 0.1% NP-40, 1 mM DTT, pH 8). The beads were transferred into a clean 1.5ml 
eppendorf tube and resuspended in 50µl of TCB. The bound complexes were eluted via 
AcTEV digest (3x 80U; Invitrogen) for 30min at 37°C.  The TEV elutes were combined 
and incubated 2hrs at 4°C under gentle rotation with 40µl of solid Strep-Tactin beads 
(Qiagen), pre-equilibrated with 500µl wash buffer-II (100 mM Tris pH 8.0, 150 mM NaCl, 
1 mM EDTA, 1 mM DTT). The doubly purified protein complex was recovered by 2 X 
100 μl additions of elution buffer (StrepII-tag: 100 mM Tris 
pH 8.0, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 40 mM Desthiobiotin [IBA]) with 5 min 
of agitation between each elution.  Samples collected at each step were analyzed by 
western blot (rabbit anti-Chd2 antibody [1:4000]) to monitor purification progress and 
yield. 
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2D-LC/MS/MS analysis:  Sample preparation for mass spectrometry analysis was 
performed according to the protocol established by Organic and Biological Mass 
Spectrometry group at Dr. Hayes McDonald‟s laboratory, Oak Ridge National 
Laboratory. Briefly, the affinity purified protein complex was concentrated by 
trichloroacetic acid (TCA) precipitation and denatured by resuspending the concentrated 
protein in 50mM Tris buffer containing 8M urea and 15mM DTT. The denatured 
samples will be diluted to make the final concentration of urea 1M, followed by trypsin 
digestion of the samples added at 1:20(w/w) at 370C overnight (Connelly et al., 2006).  
The samples were desalted with an Omics 100µl solid phase extraction pipette tip 
(Phenomenex, Torrance, CA, USA) [211]. 2D-LC/MS/MS analysis of the samples was 
performed with a reverse-phase HPLC (high performance liquid chromatography) 
system coupled to a linear trapping quadrupole (LTQ) mass spectrometer (Thermo 
Electron Finnigan, San Jose, CA, USA) with a nano-electrospray ionization source. The 
mass spectrometer was operated in data-dependent mode to generate a tandem 
(MS/MS) mass spectrum [211]. 
Data analysis: The tandem mass spectra obtained were analyzed using computer 
algorithm – SEQUEST. SEQUEST correlates the tandem mass spectra of peptides with 
amino acid sequences from protein and nucleotide databases. The algorithm generates 
a theoretical fragmentation pattern for amino acid sequences in the database and 
matches to the observed tandem MS [212].  The MS data obtained from SEQUEST 
were sorted and filtered at one-peptide level using DTASelect software to obtain a list of 
potential interacting proteins of CHD2 [213]. The proteins were further classified based 
on their biological functions using the program-The Protein Information and Property 
Explorer.  
 
Single step purification of CHD2 protein complex using Ni-NTA beads 
Exponentially growing cells of ChdkthRR3 [stable cell line expressing the first 1395 
amino acid Chd2 recombinant peptide with the dual affinity tags (Strep-TEV-
6XHis)],1KSH [stable cell line expressing the first 447 amino acid Chd2 recombinant 
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peptide with the dual affinity tags (Strep-TEV-6XHis)] and PDYM (stable cell line 
established by transfecting with empty vector) were harvested and re-suspended in a 
3X volume (of the cell pellet) of cold cytoplasmic buffer (10mM Tris HCl pH 7.9, 0.34M 
sucrose, 3mM CaCl2, 2mM Mg-Acetate, 0.1mM EDTA, and protease inhibitors) and 
centrifuged  at 3,500 X g for 15 min at 40C. The nuclear pellet obtained was re-
suspended in 3X volume of cold TAP lysis buffer. The cell lysates were sonicated for 20 
seconds in ice. The sonicated lysates were spiked with 3mM MgSO4 and 1mM CaCl2 
and treated with 1μl of 50units/µl of micrococcal nuclease for 20 min at room 
temperature. Protein concentrations were determined using a BCA kit (Pierce). Five 
milligram of nuclear extract was incubated for 2hrs at 4°C under gentle rotation with 
25µl of solid Ni-NTA beads (Qiagen), pre-equilibrated with 500µl wash buffer-I.  The 
beads were transferred to 15ml falcon tube and washed three times with  3 ml of wash 
buffer-I.  Bound protein complex was eluted with 2X 125µl of imidazole elution buffer 
(100 mM Tris, 150 mM NaCl, and 200 mM imidazole). The eluted samples were 
dialyzed overnight with DPBS [Dulbecco‟s phosphate buffered saline (HyClone)] and 
precipitated with TCA (6% [v/v]). The protein pellet was redissolved in 1X SDS-gel 
loading buffer (50mM Tris-HCl pH 6.8, 2% SDS, 0.1% bromophenol blue, 10% glycerol, 
and 100mM DTT) and separated on 4-15% gradient Criterion Tris-HCl gels (BioRad). 
Proteins were visualized with GelCode Blue Stain Reagent (Thermo Scientific). Protein 
bands not seen in control (PDYM) pull-down lane but seen in the lanes containing the  
ChdkthRR3 and 1KSH elutes were cut and collected in 1.5 ml eppendorf tubes with 30µl 
sterile dH2O. The protein gel bands were sent to Applied Biomics (Hayward, CA) for 
Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry analysis.  The 
tandem mass spectra obtained were analyzed using computer algorithm – Mascot. 
 
Co-immunoprecipitations of CHD2 and PSP1 from whole cell lysate 
Actively growing culture of U2OS were treated with 10Gy radiation of X-ray dose and 
harvested 2hrs later. Untreated and treated pelleted cells were resuspended in 4X 
packed volume of lysis buffer (50mM Tris pH 8.0, 150mM NaCl, 0.1% NP-40, 10 mM β-
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mercaptoethanol, and 10% glycerol and protease inhibitor) and incubated on ice for 15 
min. The cell lysates were sonicated for 10 seconds in ice. The sonicated lysates were 
spiked with 3mM MgSO4 and 1mM CaCl2 and treated with 1μl of 50units/µl of 
micrococcal nuclease for 20 min at room temperature. Protein concentrations were 
determined using a BCA kit (Pierce).  400 µg of extracts were pre-cleared with 5µl of 
50% slurry of protein A sepharose beads pre-equilibrated with modified Net gel buffer 
(50mM Tris pH 8.0, 0.1% NP-40,1mM EDTA, 0.25% gelatin, 2% BSA and protease 
inhibitors) for 20min at 40C.  The pre-cleared extracts were then incubated with an 
antibody against CHD2 and PSP1 (Paraspeckle Protein 1: gift from Dr. Yasuyuki 
Kurihara, Yokohama National University, Japan) overnight at 40C. The protein complex 
was immunoprecipitated by incubating with 10µl of 50% slurry of pre-equilibrated protein 
A-sepharose beads at 40C for 2hrs. The immunoprecipitated fractions were washed 3X 
with wash buffer (20mM Tris pH 8.0, 100mM NaCl, and 0.05% Tween-20).  The washed 
fractions were subjected to SDS-PAGE and immunoblotted with 1:2000 dilutions of anti-
Psp1 antibody (mouse monoclonal) and/or rabbit anti-Chd2 antibody (1:4000).  
 
In vivo splicing assay 
The assay was performed as previously described [214]. The pMTE1A minigene 
plasmid (3µg) (kind gift from Dr. A.Krainer, Cold Spring Harbor Laboratory) was 
transfected either alone or together with an increasing amount (2, 4, 6, 8 µg) of YP2 into 
U2OS cells. The empty parental vector pcDNA 3.1 was added to ensure equal DNA 
concentration in each transfection. RNA was isolated after 48hrs of transfection using 
TRizol according to manufacturer‟s protocol (Invitrogen). Genomic DNA was removed 
by incubating RNA samples with 2U of RNase-free deoxyribonuclease I (Promega) per 
5µg of RNA for 30 minutes at 370C. First strand cDNA synthesis was performed with 
2.5µg of total RNA using random hexamers and M-MLV reverse transcriptase 
(Promega). 
The PCR was performed with 2.5µl of the reverse transcription reaction using 
primers; 5'-ATTATCTGCCACGGAAGGTGT-3' (sense) 5'-
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GGATAGCAGGCGCCATTTTA-3' (antisense) [214]. The PCR conditions were; initial 
denaturation at 940C for 2min followed by 28 cycles of 940C for 1min, 580C for 2min and 
720C for 2min and then final extension at 720C for 5mins. The bands were visualized 
and quantified using EpiChem3 darkroom gel documentation (UVP, CA) and LabWorks 
acquisition & analysis software respectively.  Three independent experiments were 
performed.  
 
Results 
 
5.1. CHD2 interacts with p53 
To detect association of endogenous CHD2 with endogenous p53, U2OS cells were 
exposed to 10Gy X-ray radiation, incubated for 2hrs and immuno precipitated with anti-
Chd2 antibody. Immunoblot analysis with anti-p53 antibody showed an interaction of 
p53 with Chd2. This interaction was greatly enhanced after X-ray treatment (Fig.24).  
 
 
 
 
 
 
 
 
 
U20S cells were either mock treated (−IR, control) or exposed to 10Gy IR (+IR), 
immunoprecipitated with anti-Chd2 and immunoblotted with anti-p53 antibodies. 
 
 
 
 
 
Figure 24. Endogenous interaction of CHD2 with p53 
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To verify the interaction, recombinant HA-tagged Chd2 (1-1395 a. acids) and Flag-
tagged p53 were expressed in U2OS cells and were immunoprecipitated with HA 
beads. Western blot analysis with anti-p53 antibody showed robust association between 
the recombinant proteins (Fig.25). 
 
5.2. Tandem affinity purification (TAP) of CHD2 complex and mass spectrometric 
analysis 
To identify CHD2 interacting proteins and its potential interaction with DNA damage 
response proteins (DNA repair and checkpoint proteins), to understand the functional 
pathways regulated by CHD2, a tandem affinity purification approach coupled with mass 
spectrometry (MS) was performed for the identification of CHD2 interacting partners. 
Stable cell lines expressing a recombinant clone consisting of the first 1395 amino acid 
Chd2 recombinant peptide with the dual affinity tags (ChdkthRR3 :6X His and Strep 
tags with a TEV cleavage site in between[TAP tag]) was used for the experiment. Stable 
cell lines expressing the empty TAP vector (PDYM) were used as controls for the 
experiment. To verify if CHD2 associated with a different set of proteins after DNA 
damage, cells were exposed to different DNA damaging agents such as 10Gy IR-1hr, 
10Gy IR-4hr and 10J U.V-4hrs and the cell lysates obtained were then preceded with 
the purification.  
The protein complex containing CHD2 and its interacting partners was purified using 
the TAP purification protocol provided by Dr. Yisong‟s laboratory.  Aliquots collected 
prior to the purification, during purification steps and the final eluted protein complex 
were analyzed by western blot using anti-Chd2 antibody to ascertain the recovery of 
tagged Chd2 (Fig.26). The strep elutes for each of the sample was analyzed by silver 
staining also (Fig.27). 
The purified strep elutes were sent for two-dimensional liquid chromatography nano-
electrospray ionization tandem mass spectrometry (2D-LC/MS/MS) analysis to Dr. 
Hayes McDonald (Oak Ridge National Laboratory). 
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Co-immunoprecipitation experiments using lysates prepared from U2OS cells 
transfected with HA-tagged Chd2 and Flag-tagged p53, followed by immunoblot 
analysis with anti-p53 and anti-HA antibodies. Chd2-HA ST = U2OS cells stably 
transfected with HA-tagged Chd2, IB= Immunoblot, IP= Immunoprecipitation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aliquots collected during the purification were resolved on a 10% SDS-PAGE and 
probed using 1:4000 diluted anti-Chd2 antibody. 
 
Figure 25. Interaction of recombinant p53 and CHD2 
Figure 26. TAP purification of ChdkthRR-3 (1395 a.a clone) stable clone 
  
89 
 
The tandem mass spectra obtained were analyzed using computer algorithm – 
SEQUEST against the human database and then sorted using DTASelect software to 
obtain a list of potential CHD2 interacting proteins. The proteins were further classified 
based on their biological functions using the program-The Protein Information and 
Property Explorer (Table-3).  
 
5.3 Identification of CHD2 interacting proteins through single step purification 
using Ni-NTA beads 
Although TAP protocol is the most efficient way of obtaining purified protein 
complexes under physiological conditions, single step purification has its own 
advantages. Single step purification is simple, less time consuming and prevents the 
loss of transiently and weakly interacting proteins [215].  Single step purification of 
nuclear extracts obtained from ChdkthRR3, 1KSH and PDYM were performed as 
described in materials and methods. 
TCA precipitated samples were thereafter separated by 4-15% Tris-HCl gradient gel 
and stained with GelCode Blue Stain Reagent.  Several protein bands were identified to 
specifically co-purify with CHD2 protein, as they did not appear in the control lane (elute 
from PDYM) (data not shown).  The protein bands of interest were excised from the gel 
and sent to Applied Biomics for mass spectrometric analysis.   
Applied Biomics analyzed the resulting peptide fragment spectra using MASCOT and 
identified three proteins with high confidence: chromodomain helicase DNA binding 
protein 2 isoform CRA_a [Homo sapiens] , SFPQ protein [Homo sapiens] , and non-
POU domain containing, octamer-binding isoform 1(p54NRB/NONO) [Homo sapiens] . 
SFPQ protein [Homo sapiens], and non-POU domain containing, octamer-binding 
isoform 1(p54NRB/NONO) belong to the DBHS (Drosophila melanogaster behavior, 
human splicing) family of proteins.  These proteins are found in the paraspeckle of the 
nucleus and are known to involved in an array of functions specifically in transcription 
and RNA processing [216].  
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Proteins interacting with CHD2 were isolated by tandem affinity purification of 
untransfected U2OS cells and cells stably transfected with recombinant Chd2 peptide 
(RR3) , resolved on a 4-20%SDS-PAGE gel and visualized by silver staining. 20μls of 
the final strep elutes were loaded on the gel. Strep elutes obtained from the purification 
of the cells (U2OS and RR3) treated with 10Gy radiation were also loaded. 
 
 
 
 
Figure 27. Identification of CHD2 associated proteins 
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Table-3: GO classification of the CHD2 interacting nuclear proteins based on biological 
function using The Protein Information and Property Explorer program. 
 
 
 
3.4 Effect of CHD2 on alternative splicing  
The mass spectrometric analysis of CHD2 interacting protein partners obtained 
through tandem affinity purification and single step purification showed potential 
interaction of CHD2 with proteins involved in pre-mRNA processing events [217-219].  
One of the interacting proteins, p54nrb is specifically shown to influence the splicing 
pattern of collagen, type II, α 1 (Col2a1) mRNA [220]. Furthermore, the CHD1 protein 
that is closely related to CHD2 has been show to interact with the splicing components 
[51-52]. The mass spectropmetry data suggested that the CHD2 protein plays a 
potential role in regulation of pre-mRNA splicing. To test this possibility, an in vivo 
splicing assay based on the alternative splicing of the adenoviral E1A gene was utilized.  
The concentration of the splicing proteins, constitutive signals, and  other regulatory 
proteins in a cell is known to affect the alternative splicing pattern of many genes [221].  
The E1A pre-mRNA of adenovirus utilizes three alternative 5‟-splice site and a common 
3‟-splice site to form different mRNAs 13S, 12S, 11S, 10S, and 9S [222-223]. The E1A 
minigene system has been successfully used to demonstrate the role of many proteins 
in pre-mRNA splicing. These proteins have been shown to affect the splicing pattern of 
the E1A mRNA in a dose dependent manner [214, 221, 223-225]. In our experiments, 
transfection of E1A minigene plasmid into Hela cells resulted in four alternative splice 
Biological Function  Number of proteins  
RNA metabolism, processing, regulation  9  
Protein metabolism, synthesis  1  
Nuclear organization  
and biogenesis  
5  
Immune Responses  1  
Neuroblast differentiation  1  
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forms of E1A 13S, 12S, 10S and 9S.  When the cells were co-transfected with 
increasing amounts of YP2 plasmid (plasmid expressing the full length FLAG tagged 
Chd2) along with constant amount of E1A, a modification in the splicing pattern was 
observed. Addition of YP2 resulted in an increase of the 9S form from 2.2 % to 4.5% 
and a slight decrease in the 13S forms from 59.4% to 58.4% in a dose-dependent 
manner (Fig.28A and B).  There was also an increase in 10S form from 5.8% to 7% and 
decrease in 12S forms from 32.4% to 29.9% (Fig.28A and B).  These results 
demonstrate that over expression of Chd2 appears to favor use of distal (9S) 5′ splice 
site in the E1A gene, thus, confirming that CHD2 is engaged in alternative splicing 
modulation. 
 
5.5 Interaction of CHD2 and PSP1 
Isoform 1 of Paraspeckle component 1 was identified as the protein with maximum 
high scoring peptides assigned to it from the MS data analysis of the tandem affinity 
purified CHD2 complex. Paraspeckle protein 1(PSP1/PSPC1) is a component of a 
nuclear body known as paraspeckle.  It contains a DBHS (Drosophila behavior, human 
splicing) motif also found in PSF (Polypyrimidine tract-binding protein-associated 
splicing factor) and p54nrb/Nono (non-POU domain containing, octamer-binding) 
proteins. Both PSF and p54nrb/Nono are known to bind to RNA sequences in 
premRNA. These are known to play an important role in transcription as well as in RNA 
processing [219]. Mouse paraspeckle protein 1 was identified as a RNA-binding protein 
and was shown to dimerize with PSF and p54nrb/Nono [226].  To confirm the specificity 
of the interaction between PSP1 and CHD2, an in vivo co-immunoprecipitation study 
was performed. The results show that endogenous PSP1 is not co-immunoprecipitated 
by the rabbit polyclonal Chd2 antibody. Reciprocal immunoprecipitation confirmed these 
results as Chd2 would not be immunoprecipitated using a mouse monoclonal Psp1 
antibody (Fig.29). 
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(A) Pattern of E1A alternative splicing in Hela cells upon transfection of the E1A 
minigene and cotransfection of increasing amounts Chd2 (YP2) plasmid. Top panel 
shows agarose gel picture of the PCR products of one experiment.  The lanes Sp1, 
Sp2, Sp3, Sp4 and Sp5 represent different reactions in the experiment. Each reaction 
contains cells transfected with constant amount of E1A plasmid but different amounts of 
the Chd2 (YP2) plasmid. The total amount of transfected DNA was kept constant by the 
addition of the empty parental vector pcDNA 3.1. The upper panel shows the amounts 
of E1A, Chd2 (YP2) and the empty vector pcDNA 3.1 present in each reaction.  (B) 
Quantification of the alternatively spliced forms of E1A mRNA (13S, 12S, 10S and 9S) 
upon cotransfection with increasing amounts of Chd2 (Sp1, Sp2, Sp3, Sp4 and Sp5). 
Three independent experiments were performed. Average percentage with std.dev of 
each isoform is shown. 
 
Figure 28. CHD2 affects the splicing pattern of E1A minigene 
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                                  “Figure [figure number 28] continued” 
 
 
 
 
 
 
 
 
 
 
 
 
 
To test the interaction of endogenous CHD2 and PSP1 protein, U2OS lysates were 
incubated with rabbit anti-Chd2 antibody, mouse anti-PSP1/PSPC1 antibody or no 
antibody control and pulled down by Protein A beads. Immunoprecipitated proteins were 
separated by SDS-PAGE gel and blotted by a mouse anti-PSP1 or rabbit anti-Chd2 
antibody. IP = Immunoprecipitation. 
 
 
Figure 29. Co-immunoprecipitation of PSP1 and CHD2 
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Discussion 
The CHD family of proteins is a novel class of chromatin remodeling proteins that 
contain not only a Swi/Snf-like helicase-ATPase but also two chromodomains as well as 
a DNA-binding domain.  These proteins are reported to play an important role in 
regulating development, gene expression and oncogenesis [34, 187, 227]. Recently, 
one of the CHD family members, the CHD8 protein was reported to bind to histone H1 
and p53 resulting in the recruitment of histone H1 by CHD8 to the promoter of p53 
target genes(p21and Noxa) to downregulate their transcription [89].  Interestingly, Chd2 
mutant thymocytes and MEF were found to be defective in their ability to induce the pro-
apoptotic gene, PUMA and p21, a gene involved in cell cycle arrest (George Samaan 
and Venkatachalam, unpublished observations). p21 and PUMA [p53 up-regulated 
modulator of apoptosis] are transcriptional targets of p53 and induce cell cycle arrest 
and apoptosis respectively [228]. Thus we sought to determine whether CHD2 directly 
interacts with p53 and modulates the activity of p53 target genes. In order to investigate 
the possibility of direct interactions of CHD2 with p53, we performed 
immunoprecipitation using antibodies to p53 or CHD2 on U2OS cell lysates. Our results 
show that anti-Chd2 antibody was able to effectively pull-down the p53-CHD2 complex. 
This interaction was enhanced when the cells were exposed to IR. These results were 
validated by performing pull-down assays with cells expressing recombinant p53 and 
Chd2 peptides. These results show that CHD2 play an essential role both in the early 
and late stages of DDR pathway.  CHD2 can affect the p53 transcriptional activity by 
two mechanisms. CHD2 can facilitate post-translational modifications on p53 through 
recruitment of co-activators to p53, which would lead to stabilization and activation of 
p53. For example, co-activators such as CBP/p300 (cAMP response element binding 
protein (CREB)-binding protein) and PCAF (p300/CBP associated factor) have been 
demonstrated to bring about acetylation of p53 which enhances its transcriptional 
activity [229-230]. Interestingly, in the absence of genotoxic damage, CBP has been 
shown to destabilize p53 through interaction with a chromatin remodeler protein BRG1 
(component of Swi/Snf complex) [231]. The second mechanism would be that CHD2 
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modulates the acetylation patterns of the chromatin structure on the promoter regions of 
p53-target genes or remodels the chromatin, enabling easy access for p53. Consistent 
with this model, recent studies have demonstrated the role of some ATP-dependent 
chromatin remodeling proteins such as SWI/SNF complex, CHD8 and NuRD complex in 
regulating the transcriptional activity of p53 [89, 118, 232]. Further studies into how 
CHD2 affects the transcriptional activity of p53 will be of great importance and interest. 
In addition to interacting with specific proteins, some of the CHD proteins are known 
to be critical for the functioning of multiprotein complexes involved in transcriptional 
regulation. For instance, yeast Chd1 is reported to be a component of yeast SAGA (Spt-
Ada-Gcn5 acetyltransferase) and SLIK (SAGA-like) complex involved in regulation of 
transcription activity [46].  CHD1 was also shown to associate with HMG box-containing 
protein, SSRP1, component of FACT complex [42].  CHD3 and CHD4 are part of the 
nucleosome remodeling and deacetylating (NuRD) complex involved in transcription 
repression[142].  CHD4 was shown to coimmunoprecipitate with ATR, HDAC2 and 
centrosomal protein pericentrin [64, 142].  These data suggest that CHD2 might also 
function as a component of a multiprotein complex.  Thus a tandem affinity purification 
approach combined with mass spectrometry was adopted to identify the protein 
partners of CHD2 to dissect the biological pathways in which CHD2 functions.  
The tandem affinity purification approach combined with mass spectrometry is a 
powerful approach to identifying the composition of protein complexes [233]. It is a 
rapid, easy technique which helps to identify true interacting protein partners under 
physiological conditions with minimum background [234]. Application of this technique in 
mammalian cells has lead to identification of many novel interactions. Some examples 
include, the interaction between SMAD3 and HSP70 [235] and  protein partners of 
telomeric repeat binding factor 2 (TRF2) [210].  In this study, the Chd2 gene encoding 
all the structural domains was cloned into a 6X histidine-TEV-Streptavidin tagged vector 
and expressed in U2OS cells. Tandem affinity purification followed by mass 
spectrometric analysis was performed on CHD2 protein complex. We identified proteins 
that are involved in various cellular processes such as proteins involved in RNA 
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metabolism, processing, regulation, protein metabolism, nuclear organization, immune 
responses and neuroblast differentiation. These results highlight the functional diversity 
of CHD2 protein. Isoform 1 of Paraspeckle component 1 was one of the „high-
confidence‟ proteins obtained from the MS data analysis of TAP purified CHD2 
complex. Paraspeckle component 1is a RNA-binding protein and was shown to play a 
role in RNA processing [219].   
Mass spectrometric analysis of single step purified CHD2 protein complex showed 
presence of two paraspeckle proteins, SFPQ/PSF and p54NRB/NONO in the complex.  
There are three proteins in the paraspeckle family-PSF/SFPQ, P54nrb/NONO, and 
PSPC1 [paraspeckle protein 1]. P54nrb/NONO and PSP1/PSPC1 have been shown to 
form a heterodimer and localize to the paraspeckle in the nucleus [236]. The 
paraspeckle proteins along with the long nonprotein-coding RNA NEAT1 (MEN-
epsilon/beta) form the paraspeckle structure [216].  PSF/SFPQ and P54nrb/NONO are 
known to be involved in nuclear retention of RNA as they prevent A to I hyperedited 
RNA from leaving the nucleus [216]. PSF and p54nrb were initially identified as 
essential pre-mRNA splicing factors needed for spliceosome formation [217, 219, 237]. 
Interestingly, some CHD proteins have also been reported to play roles in RNA 
processing. For example the CHD1 protein that is closely related to CHD2 has been 
shown to have a role in pre-mRNA splicing [51-52]. CHD1 interacts with splicing 
proteins mKIAA0164, Srp20 and Saf-B and affects the pre-mRNA splicing pattern of 
Clk1 minigene. Overexpression of CHD1 resulted in 20% shift towards exclusion of the 
alternatively spliced exon in Clk1 mRNA [51]. CHD6 has been shown to colocalizes with 
phorsphorylated forms of RNA polymerase II (RNAPII) and is present in loci of mRNA 
synthesis [76].  CHD8 has also been shown to associate with the elongating form of 
RNAPII and is involved in expression regulation of cyclin E2 gene [90].  
The paraspeckle proteins are now known as “multifunctional proteins” involved in 
transcription initiation, coactivation, and corepression, constitutive and alternative 
splicing and transcriptional termination and DNA repair [216, 238]. A biochemical study 
demonstrated that PSF-p54/nrb complex binds to the DNA substrates of the non-
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homologous end joining reaction and helps Ku protein to form a functional preligation 
complex [239]. Interestingly, PSF has also been shown to bind to both single-stranded 
(ss) and double-stranded (ds) DNA and promote homologous pairing [240].  More direct 
evidence of PSF‟s role in homologous pairing was shown in which purified human PSF 
was able to bind with RAD51 and promote RAD51-mediated homologous pairing [241]. 
Recently, an in vivo study with p54nrb in human cells has highlighted its important role 
in DNA double-strand break repair [242]. Cells negative in p54nrb displayed a 
significant delay in recovery from DNA damage as these showed persistence of γ-H2AX 
foci 2hrs post treatment with gamma radiation. p54nrb attenuated cells also showed 
increased chromosomal aberrations and increased radiosensitivity after treatment with 
gamma radiation [242]. The authors of this article speculate that p54nrb may function 
with specific protein partners to bring about the repair of DNA double strand break [242]. 
Additionally, it has been shown previously that DNA topoisomerase I directly interacts 
with PSF-p54nrb complex [243]. 
Collectively, these observations by other groups and our results lead us to 
hypothesze that CHD2 associates with the paraspeckle proteins to facilitate their 
function in pre-mRNA splicing and DNA double-strand break repair. Experiments 
conducted in the first aim of this thesis show that CHD2 plays a vital role in maintaining 
genomic stability by affecting the efficiency of DNA repair. Chd2-mutant cells treated 
with X-ray radiation exhibited a delay in DSB repair in a comet assay. These cells also 
showed a significant increase in X-ray radiation induced chromosomal aberrations. 
Thus it is possible that CHD2 brings about remodeling of chromatin near the DNA 
damaged sites and also facilitates recruitment of the paraspeckle proteins to the 
damaged sites. It would be interesting to see if the levels of any of the paraspeckle 
proteins-PSF, p54nrb/NONO or PSP1/PSPC1 are low or completely absent in the Chd2 
mutant cells. 
To investigate whether CHD2 could modulate the pre-mRNA splicing event, we 
performed an in vivo splicing assay. An in vivo assay performed with E1A minigene 
showed that overexpression of CHD2 strongly activated distal 5‟ splice site of the E1A 
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gene, giving rise to an increase in the amount of 9S and decrease in 13S. These results 
implicated that CHD2 would regulate alternative splicing events. Interestingly, recent 
studies have demonstrated that changes in chromatin structure affect RNA splicing 
process [244-245]. Splicing is shown to be tightly coupled to transcription as introns are 
removed while the nascent transcript is still attached to the transcribed gene. This 
process is carried out by RNA pol II via association with many splicing factors [246]. The 
transcription rate of RNA pol II have also been shown to affect splicing [247]. 
Furthermore, recent studies have shown that the ATP-dependent chromatin remodeler, 
Brahma (hBrm), subunit of SWI/SNF complex delays the transcription rate of RNA pol II 
and associates with the splicing machinery proteins such as U1 and U5 snRNPs, 
resulting in modulation of alternative splicing pattern of several SWI/SNF target genes 
via favoring inclusion of variant exons [248-249]. Additionally, nucleosome positioning 
and post-translational modifications on histones have been shown to affect the rate of 
RNAPII elongation [244].  Interestingly as mentioned before, CHD1 has been shown to 
affect the pre-mRNA splicing pattern of Clk1 minigene. [51-52]. And CHD6 and CHD8 
have been shown to associate with RNA polymerase II [76, 90].  
CHD2 seems to play a role in modulating both pre-mRNA splicing and repair of DNA 
damage as the paraspeckle proteins. Additionally, the mass spectrometric analysis 
shows that the paraspeckle proteins could be potential interacting partners of CHD2. 
Thus, co-immunoprecipitation studies were performed to test whether Chd2 directly 
interacts with any of the paraspeckle proteins. However, co-immunoprecipitation study 
of CHD2 with PSP1/PSPC1 failed to show any direct interaction of CHD2 with 
PSP1/PSPC1.  Since there is paucity of commercial reagents available for the 
PSP1/PSPC1 protein and the antibody used in this study was generated by another lab, 
it may not be efficient for IP.  Alternatively, as CHD2 possibly interacts with the second 
member of the paraspeckle protein family-p54nrb/NONO (data from the second mass 
spectrometric run; see result section), and since PSP1/PSPC1 forms a heterodimer with 
p54nrb/NONO [236], it is possible that PSP1 is present in the CHD2-p54nrb complex, 
but does not directly interact with CHD2. Additionally, it is also possible that the 
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interaction between CHD2 and the paraspeckle proteins is transient and would need 
better biochemical approaches to test the direct association. Nevertheless, analysis of 
CHD2 binding proteins using MS is a very feasible and constructive approach to gain 
insight into the biological importance and functions of this protein.  
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Conclusion: “CHD2 a multi-function protein?” 
ATP-dependent remodeling proteins are essentially regarded as transcriptional 
regulators.  These proteins utilize the energy from ATP hydrolysis to modulate and 
reposition nucleosomes so that the transcription machinery can access the DNA 
template [250-252]. However, recent studies have shown that the ATP-dependent 
chromatin remodeling proteins function much more diversely than just as transcriptional 
regulators. ATP-dependent remodeling proteins like INO80 and SWR1 have been 
shown to play critical role in processes such as DNA repair, checkpoint regulation, DNA 
replication, telomere maintenance, and chromosome segregation [28, 158]. Similarly the 
SWI/SNF chromatin remodeling complex have been demonstrated to be involved in an 
array of functions such as in differentiation, in tumor suppression, in the control of cell 
proliferation, in DNA repair, in cellular adhesion, in immune responses, T-cell 
development and recombination events [253-255]. The CHD family of chromatin 
remodelers have also been implicated in diverse cellular functions (described in chapter 
I of this thesis). Though the ATP-dependent chromatin remodeling proteins have been 
shown to be involved in various cellular processes, it is not still clear whether these 
diverse functions are dependent or independent of the chromatin remodeling activity of 
these proteins. Thus the roles of CHD2 in DNA repair, cellular responses to DNA 
damage and tumor suppression elucidated in this thesis may be due to the direct 
chromatin remodeling activity of CHD2 or indirect effects on the transcriptional 
regulation of specific target genes. Based on our observations relating to the DNA repair 
defects, DNA damage induced phosphorylation and interaction of CHD2 with ATR (and 
paraspeckle proteins) we propose that CHD2 is a multi-functional protein that potentially 
facilitates both the pre-mRNA splicing process and the initial DNA repair process. A 
schematic model for the role of CHD2 in DNA repair is shown in figure 30. Briefly, upon 
DNA damage induction, activated ATM/ATR catalyzes the post-translational 
modification of CHD2. This modification could either aid in enhancing the interaction of 
CHD2 with the paraspeckle proteins or could help in activating CHD2‟s function as a 
chromatin remodeler.  The activated CHD2 remodels the chromatin around the 
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damaged site and facilities recruitment of the paraspeckle proteins. The paraspeckle 
proteins interact with the NHEJ proteins to bring about the repair of the DNA DSB.   
At the transcriptional level, our data show that CHD2 plays a role in the 
downstream process of the DDR pathway.  The interaction of CHD2 with p53 and the 
loss of the p53 transcriptional target PUMA in thymocytes suggests that the CHD2 
protein facilitates p53 transcriptional activity either by enhancing the post-translational 
modifications on p53 or by remodeling the chromatin around the promoter regions of 
p53-target genes to facilitate the interaction of p53 to its cognate sites.  A schematic 
representation of the role of CHD2 in facilitating p53 transcativation is shown in Figure 
31. Interestingly, our studies also show that the CHD2 protein has a potential role in 
mRNA splicing of exogenously expressed E1A minigene.  However, the functions of 
CHD2 in pre-mRNA splicing of endogenous genes remain to be ascertained.  Future 
studies as to how Chd2 is involved in the regulation of the vital cellular processes  of  
pre-mRNA splicing, DNA repair and DNA damage induced transcriptional activation of 
stress response genes would be of great importance to dissect the functions of CHD2 at 
the molecular and cellular levels.  Finally, the knowledge regarding CHD2 function as a 
chromatin remodeler comes from implications derived from bioinformatics analysis of its 
structural domains and comparative functional analysis of other CHD members.  Thus, it 
would be valuable to demonstrate its chromatin remodeling activity experimentally to 
provide direct evidence for the role of CHD2 in chromatin remodeling. 
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CHD2 can be phoshorylated by ATM/ATR kinase upon DNA damage. Phosphorylated 
CHD2 facilitates chromatin remodeling and recruitment of the paraspeckle proteins to 
damaged site.  The paraspeckle proteins associate with NHEJ proteins to bring about 
repair of damaged DNA. 
 
 
 
 
 
 
 
Figure 30. A model illustrating a role of CHD2 in DNA damage response 
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CHD2 can have a potential role in the downstream process of DDR by modulating p53‟s 
transcriptional activity.  It can do this by either facilitating post-translational modifications 
on p53 through recruitment of co-activators to p53 or by modulating the acetylation 
patterns of the chromatin structure on the promoter regions of p53-target genes or 
remodel the chromatin around the promoter region. 
 
 
 
 
 
 
 
 
Figure 31.Role of CHD2 in transactivation of p53 dependent target genes 
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